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ABSTRACT 
Measurement of hydrogen peroxide (H2O2) concentration and pH in 
exhaled breath condensate (EBC) is useful for detection and monitoring of 
diseases of the lower respiratory tract in humans, including asthma and 
chronic obstructive pulmonary disease. In contrast, limited information on 
the use of these parameters for the investigation of lower airway 
inflammation (LAI) is available for horses. Aims of the current study were 
to develop a device to collect EBC from non-sedated horses, assess inter-
day and intra-day variability of EBC H2O2 concentration and pH and 
determine if there was an association between these parameters and the 
presence and severity of LAI. The methodology used for collection of EBC 
was adapted from that used in a previous study (Wyse et al. 2005) and 
was evaluated for its repeatability. Hydrogen peroxide was measured 
using previously reported analytic methods (Wyse et al. 2005). During 
studies for the determination of a methodology for measurement of pH in 
EBC, samples of EBC were divided into 3 aliquots. One aliquot was left 
non-deaerated, one aliquot was deaerated with argon and one aliquot 
underwent standardisation with CO2. The pH of each aliquot was 
measured using a bench pH meter. The most repeatable measurement of 
EBC pH was obtained from plain samples (i.e. non-dearated). Intra-day 
and inter-day variability of H2O2 concentration and pH were assessed by 
collecting and analysing EBC three times a day for 3 consecutive days. For 
H2O2 the variability in concentrations was large (60-103%), while the pH 
of EBC had little variability (3-7%). No significant difference in the intra-
day or inter-day H2O2 concentrations or pH measurements were found in 
control or LAI horses, except for inter-day H2O2 concentration in horses 
with LAI (p=0.019). There was no significant difference in EBC H2O2 
concentration between control horses (Mean +/- SD) and horses with LAI 
(mean +/- SD). There was no significant difference in EBC pH between 
control horses (Mean +/- SD) and horses with LAI (mean +/- SD), 
however a trend for a reduced pH in horses with LAI was observed (p= 
0.079). The results of this study suggest that EBC H2O2 concentration is 
 ii
not suitable for detecting mild LAI or monitoring horses with LAI due to 
the high variability. The pH of EBC is more stable overtime and the 
measurements are more repeatable than H2O2 concentration and further 
studies are required to improve the stability of its measurement and to 
assess its sensitivity in a population of horses with more severe LAI 
against healthy controls. Further studies are also required to determine 
whether determination of H2O2 concentration in EBC is useful for detection 
of marked LAI in horses. 
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CHAPTER 1 - INTRODUCTION 
 
A number of conditions are associated with lower airway inflammation 
(LAI) in horses, including recurrent airway obstruction (RAO), summer-
pasture-associated RAO (SPA-RAO) and inflammatory airway disease 
(IAD) (Dixon et al. 1995a; Couetil et al. 2007). Recurrent airway 
obstruction occurs in mature horses that are stabled and is characterised 
by accumulation of mucus, bronchospasm and neutrophilia in the lower 
airways and reversible airway obstruction. Signs include cough, 
mucopurulent nasal discharge, abnormal tracheal and lung sounds, 
decreased performance, increased respiratory effort or respiratory 
distress. The pathogenesis and clinical signs of SPA-RAO are similar to 
RAO, however the disease is more common in horses at pasture and 
prevalence is greater during summer. In contrast, horses with IAD do not 
exhibit increased respiratory effort at rest and signs of disease tend to be 
confined to cough, nasal discharge and poor performance (Couetil et al. 
2007). Inflammatory airway disease is most common in young racehorses, 
however horses of any age or breed can be affected (Couetil et al. 2007).  
 
The etiopathogenesis of LAI involves the inhalation of aerosolised 
environmental irritants and/or antigens and development of airway 
inflammation, however the mechanisms of disease remain to be 
established. Recurrent airway obstruction likely results from specific 
hypersensitivity reactions to fungal aeroallergens (McGorum and Dixon 
1993; McGorum et al. 1993a), however evidence suggests a role for non-
antigen specific inflammatory responses (i.e. to endotoxins, β-glucans) 
(Pirie et al. 2001; Pirie et al. 2003). The etiopathogenesis of IAD remains 
poorly defined and a variety of respirable irritants and antigens may be 
involved. The involvement of environmental factors in the development of 
RAO and IAD has been reinforced by studies demonstrating that 
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introduction to a stable environment is a risk factor for development of 
LAI in horses (Robinson 2001; Malikides 2003; Couetil et al. 2007).  
 
Diagnosis of LAI in horses is achieved by diagnostic imaging and/or 
cytological examination of secretions obtained from the lower airways. 
Endoscopy is useful to detect and semi-quantify the presence of mucus 
within the larger airways. Collection and analysis of a tracheal aspirate 
(TA) is often used for investigation of lower respiratory tract disease. 
Tracheal aspirate samples are used commonly for cytological and 
bacteriological examinations. However, the usefulness of TA cytology has 
been questioned by Derksen et al. (1989) who found no correlation 
between the cytological results of TA and BAL samples in a mixed 
population of horses and suggested that TA cytology does not provide 
information on the health of the lower airways. Conversely, Christley et al. 
(2001) in a study performed using Thoroughbred racehorses, documented 
a strong correlation between signs of respiratory tract disease (cough) 
and neutrophil percentage in TA samples, suggesting TA cytology may be 
useful in more homogenous populations. Cytological examination of 
bronchoalveolar lining fluid (BALF) obtained by BAL is used commonly to 
confirm the presence of airway inflammation. However, the BAL procedure 
is invasive, usually requires sedation of the animal, frequently induces 
transient signs of discomfort during the procedure and can induce 
neutrophilic airway inflammation (Sweeney et al. 1994). Consequently BAL 
is not suitable for frequent sampling to monitor horses with LAI and 
alternative methods are required. 
 
Exhaled breath condensate (EBC) has been studied widely in human 
patients with inflammatory diseases of the lower airways, including 
asthma and chronic obstructive pulmonary disease (COPD) (Jobsis et al. 
1997; Ho et al. 1999; Hanazawa et al. 2000; Niimi et al. 2004; Brunetti et 
al. 2006).  Collection of EBC is non-invasive, easy to perform and can be 
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repeated frequently as samples are not influenced by previous sampling. 
Numerous compounds are present in EBC from humans including 
hydrogen peroxide (H2O2), nitric oxide, adenosine, arachidonic acid 
metabolites, cytokines, 8-isoprostane and ammonia (Horvath et al. 2005). 
Hydrogen peroxide concentration in EBC is considered a suitable analyte 
for frequent monitoring of humans with respiratory disease (Loukides et 
al. 1998; Loukides et al. 2002; Horvath et al. 2005). Hydrogen peroxide is 
produced primarily by activated inflammatory cells in the airways as a 
consequence of oxidative stress (Babior 2000). In humans, H2O2 is also 
produced by epithelial cells in the conducting airways and expiratory flow 
rate may influence its concentration in EBC (Schleiss et al. 2000). Potential 
limitations to the use of H2O2 are that it is photo- and thermo-sensitive, 
extremely reactive towards a wide selection of materials and subject to 
rapid degradation. A wide inter-day coefficient of variation for EBC H2O2 in 
healthy humans has been reported (van Beurden et al. 2002a) and may 
be due to either chemical reactivity and instability or circadian rhythms of 
H2O2 secretion (Nowak et al. 2001). In contrast, other authors described 
good correlation between EBC H2O2 concentration and the presence and 
severity of asthma and response to treatment (Antczak et al. 2000; 
Loukides et al. 2002). Similarly, EBC pH has been demonstrated to be a 
robust and reliable indicator of inflammatory respiratory diseases in 
humans (Kostikas et al. 2002; Vaughan et al. 2003; Borrill et al. 2005). 
 
Knowledge of the usefulness of EBC H2O2 concentration and pH (including 
physiological values) in the investigation of LAI in horses is limited. 
Deaton et al. (2004a) described good correlation between the presence 
and severity of respiratory disease and H2O2 concentration in EBC in 
horses with RAO. However, no significant increase of H2O2 concentration 
in horses with RAO exposed to environmental challenge compared to 
control horses was found in other studies (Deaton et al. 2005a; Wyse et 
al. 2005). Exhaled breath condensate analysis, including determination of 
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H2O2 concentration and pH, could represent an alternative to BALF 
cytology and allow frequent assessment of horses with LAI. However, 
further validation of the methodologies for collection analysis of EBC and 
understanding of the physiologic variations in EBC H2O2 and pH in the 
horse are required.  
 
The aims of the present thesis were to: 
1. describe a technique for collection of EBC from horses 
2. describe methodologies for determination of H2O2 concentration 
and pH of EBC obtained from horses 
3. determine the intra-day and inter-day variability in EBC H2O2 
concentration and pH in a group of horses 
4. apply the use of EBC collection and analysis (H2O2 concentration 
and pH) for detection of LAI in horses. 
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CHAPTER 2 – LITERATURE REVIEW 
 
2.1 Role of Phagocytosis on Oxidative Stress 
 
2.1.1 Oxidizing Agents in Phagocytosis 
 
Phagocytes, in particular neutrophils and macrophages, are an integral 
component of innate immune responses. These cell types produce a series 
of oxidizing agents to digest and destroy phagocytised particles including 
pathogens and non-infectious material. The oxidizing agents are very 
efficient in damaging pathogens, however adjacent healthy tissues can be 
injured also, particularly with protracted inflammatory responses.  
 
Baldrige (1933) first described a transiently increased consumption of 
oxygen by neutrophils and macrophages exposed to bacteria. This process 
was named the “respiratory burst” and the increased uptake of oxygen 
was initially attributed to an increased phosphorylation in the mitochondria 
to provide the required energy necessary for the phagocytosis (Baldridge 
1933). Thirty years later, the theory of mitochondrial participation was 
questioned by the discovery that H2O2 was produced using oxygen by the 
stimulated phagocytes, thereby explaining the increased oxygen uptake 
when these cells were in the presence of an inflammatory stimulus (Iyer 
et al. 1961). 
 
There are four principal oxidizing agents present in the phagosomes of 
phagocytes: hydrogen peroxide (H2O2), nitric oxide (NO), superoxide (O2-) 
and hypochlorous acid (HOCl). These oxidising agents are produced by a 
series of reactions and each mechanism is catalysed by a specific enzyme 
(Babior 2000).   
The first of these reactions is catalysed by the membrane-bound enzyme 
NADPH oxidase and produces O2- from oxygen and NADPH:   
 5
  2O2 + NADPH  Æ 2O2- + NADPH+ + H+ 
 
Second, Superoxide dismutase catalyses the conversion of O2- to H2O2 and 
oxygen:  
  2O2-+ 2H+ Æ O2 + H2O2
 
The reaction between arginine, oxygen and NADPH is catalysed by nitric 
oxide synthase to produce nitric oxide (NO), citrulline and NADPH: 
  Arginine + O2 + NADPH Æ NO + citrulline + NADPH 
 
Last, Myeloperoxidase uses H2O2, produced from the dismutation of O2-, 
for the oxidation of halide ions (Cl-, Br-, I-) to hypohalous acids:  
E.g.: Cl- + H2O2 Æ OCl- + H2O 
 
Free radicals are compounds that contain one or more unpaired electrons 
and can be generated by non-enzymatic reactions with other free radicals. 
A common feature of free radicals is that they lead to the generation of 
another free radical by reacting with a molecule with no unpaired 
electrons. A large variety of free radical species can be generated by 
reaction with carbon, oxygen, nitrogen or sulphur.  
 
The formation of reactive oxygen and nitrogen species (RONS) is a 
consequence of aerobic metabolism. A number of RONS generating 
systems are present in the body, and are involved in the physiological 
redox modulation of the intracellular environment (Dosek et al. 2007). 
One of the most common free radicals is hydroxyl radical (OH•) that 
originates from the reaction between H2O2 and metals such as iron or 
copper in a low valence state. Other secondary products (e.g. Fe3+, OCl-) 
are a group of reactive oxidants produced in phagosomes: 
  H2O2 + Fe2+ Æ OH• + OH- + Fe3+
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Singlet oxygen (1O2) is very reactive as the two electrons present in the 
O2 molecule are paired. This free radical is believed to be responsible for 
some of the damage to the phagocytised particles in neutrophils and is 
usually produced by the reaction between hydrogen peroxide and an 
oxidized halogen: 
  H2O2 + OCl- Æ 1O2 + H2O + Cl-
 
Reactive nitrogen species such as peroxynitrite (ONOO-) are also 
commonly produced from the reaction of nitric oxide (NO) with O2-: 
  NO• + O2- Æ ONOO-
 
All these oxidants are well contained in the phagosome and contribute to 
the digestion of the phagocytised particles, however they maybe released 
with the death of the phagocyte, inducing damage to the surrounding 
tissues. 
 
2.1.2 Oxidative Stress 
 
Oxidative stress is a recognized mechanism involved in physiological 
processes, such as aging (Donato et al. 2007; Lee and Wei 2007) and also 
many pathological events such as asthma and COPD in humans (Marshall 
2001). It is usually present where there is an imbalance between the 
production of free radicals and antioxidants, such that there is a lack in 
protection against the oxidative damage induced by free radicals. 
Oxidative stress can damage many cellular components and contribute to 
the development of a wide variety of diseases including inflammatory 
processes (Ercan et al. 2006) and cancer (Toyokuni 2006).   
The cellular redox environment is preserved by enzymes that maintain it 
in a reduced state. A constant input of metabolic energy is required for 
the maintenance of enzyme function and the reduced redox state. 
Disturbances in the normal redox state may induce toxic effects to the cell 
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through the production of peroxides and free radicals that can damage 
the lipids of the cytoplasmic membrane, DNA and cellular proteins 
(Bentinger et al. 2007). 
 
Oxidative stress can be detected by quantifying free radicals or the 
products of the effect of these oxidants on cell components in body 
tissues or fluids. Markers of lipid peroxidation include 8-isoprostane, an 
indicator of oxidation of arachidonate via a non-enzymatic pathway 
(Psathakis et al. 2004) and ethane that originates from the reaction 
between RONS and lipids in cellular membranes. Lipid peroxidation has 
been studied in great detail and the mechanism is well characterized 
(Paredi et al. 2000).  
 
Protein oxidation, induced by free radicals, involves specific aminoacids as 
not all aminoacids are sensitive to oxidation. Oxidation usually begins with 
a reaction between a hydroxyperoxide protein-bound transition metal 
(iron or copper) resulting in hydroxyl radicals at the metal binding site 
(Stohs and Bagchi 1995; Gaetke and Chow 2003). Hydroxyl radicals 
oxidize individual amino acids and the subsequent reactions that occur are 
similar to lipid peroxidation (Lapenna et al. 2005). The propagation phase 
of oxidation can continue within the protein, to another protein or to a 
lipid. Oxidized proteins are often hydrolyzed back to amino-acids by 
specific proteases (Lapenna et al. 2005). 
 
Oxidation of DNA, elicited by RONS, takes place in a similar manner to 
that of proteins and requires the presence of a bound transition metal. In 
the nucleus there are two possible pathways available for repairing the 
damage; removal and replacement of the appropriate nucleotide or 
removal of oligomers of oxidized bases that are replaced by DNA 
polymerase and sealed by DNA ligase (Bentinger et al. 2007).  
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Endogenous defence mechanisms against oxidation are present in the 
body and usually involve molecules broadly referred to as antioxidants. 
These molecules terminate chain reactions started by oxidizing agents by 
removing radical intermediates and by being oxidized themselves. As a 
result, antioxidants are often reducing agents such as thiols or phenols. 
Antioxidants may be enzymatic (including superoxide dismutase, 
gluthatione peroxidase and catalase) or non-enzymatic (including ascorbic 
acid, vitamins E, vitamin B complex, carotenes and glutathione). A recent 
study in humans has also described the first-line role of Coenzyme Q; this 
enzyme has been shown to protect from the oxidization of free radicals 
both at the level of the cytoplasmatic membrane and of DNA in the 
nucleus (Navas et al. 2007). 
 
2.1.2.1 Oxidative stress in the airways 
 
Physiological and pathological conditions that are induced by or induce 
oxidative stress in the airways have been described in human studies. 
High altitude environments are characterised by lower oxygen tension in 
the atmosphere and induce oxidative stress in the airways; exercise 
exacerbates this process even in healthy and fit individuals (Araneda et al. 
2005). The intranasal administration of oxygen can induce oxidative stress 
by increasing the amount of oxygen available to be transformed to 
reactive oxygen forms (Carpagnano et al. 2006). In addition, patients with 
chronic respiratory diseases (i.e. chronic obstructive pulmonary disease 
(COPD), asthma, bronchiectasis or cystic fibrosis) and smokers are more 
likely to develop oxidative stress than healthy non-smokers (Kostikas et al. 
2003; Horvath et al. 2005). 
 
Many studies have analysed the role of oxidative stress in airway disease 
by quantifing the levels of exhaled biomarkers of oxidative stress in 
patients with different pathological conditions compared to matched 
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controls. These studies have led to ongoing developments in exhaled 
breath analysis, with wide application in patients with respiratory disease. 
Further benefit is derived from the non-invasive nature of EBC collection 
and high patience compliance.  
 
Studies of the role of oxidative stress in the lower airways of horses have 
been performed (Deaton et al. 2005a; Deaton et al. 2005b; Deaton 2006) 
and described an association between the concentration of ascorbic acid 
in BALF, EBC H2O2 concentration and presence and severity of clinical 
signs of respiratory disease in horses with RAO. Decreased concentration 
of ascorbic acid in BALF and an increased EBC H2O2 concentration in RAO-
affected horses was suggestive that oxidative stress is likely to be involved 
in the pathogenesis of RAO (Deaton et al. 2004a). 
 
Oxidative damage to cellular lipids is known as lipid peroxidation and 
results in the production of pentane and ethane gas. Detection of these 
hydrocarbons in the exhaled breath has been proposed to be useful 
parameters to monitor oxidative stress in the airways of horses (Wyse et 
al. 2004; Wyse et al. 2005). Further, exercise alone is known to be 
sufficient to induce oxidative stress in healthy horses (Wyse et al. 2005). 
 
On the basis of a limited number of studies (Deaton et al. 2004b; Deaton 
et al. 2005b; Wyse et al. 2005; Deaton et al. 2006) oxidative stress is 
likely to be related to the presence and severity of RAO in horses. A 
greater understanding of oxidative stress in the lower airways of horses 
could lead to useful and non invasive methods to detect and monitor LAI 
diseases in horses, including RAO, SPA-RAO and IAD. 
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2.2 Exhaled Breath Analysis 
 
Analysis of exhaled breath (EB) and exhaled breath condensate (EBC) in 
human respiratory medicine has undergone rapid and promising scientific 
development during the last decade. Early studies, published in the 1990s, 
demonstrated the usefulness of these procedures in problematic patients, 
such as children, that were not suitable candidates for traditional 
diagnostic procedures such as broncho-alveolar lavage (BAL) (Scheideler 
et al. 1993). The non-invasive nature of sample collection prompted the 
development of a wide range of tests for detection of compounds in EBC 
and/or EB that may serve as markers of LAI. Oxidative stress in the 
airways can lead to cellular damage and death and subsequent release of 
many different molecular products of oxidation into the airways, which are 
then removed from the airways by expiration (Battaglia et al. 2005; 
Gerritsen et al. 2005). Methodologies of EB and EBC analysis are based on 
the identification and quantification of molecules that are thought to be 
specific indicators of oxidative stress in the lower airways associated with 
pulmonary pathology. Exhaled breath is composed of a gaseous phase 
and a water vapour-saturated phase (Horvath et al. 2005). Many 
substances have been identified in the gaseous phase of breath including 
nitric oxides, adenosine, arachidonic acid and derivates, cytokines (eg. 
interleukins), stable prostaglandin-like products (eg. 8-isoprostanes, 
aldehydes, ammonia (NH3) and ammonium (NH4+) and various anions 
(ATS/ERS 2005; Horvath et al. 2005). The possible roles of several of 
these molecules as markers of inflammation and disease have been 
investigated in humans. Nitric oxide, carbon monoxide (CO), carbon 
dioxide (CO2) and ethane have been studied most extensively and their 
usefulness in the investigation of respiratory disease in humans has been 
demonstrated and reported (Kharitonov et al. 1997; de Gouw et al. 1998; 
Horvath et al. 1998; Kroesbergen et al. 1999; Montuschi et al. 2001; 
American Thoracic and European Respiratory 2005).  
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The water vapour-saturated phase of EB can be collected as EBC. Greater 
than 99% of EBC is water and the remaining is a combination of 
hydrophobic and hydrosoluble non-volatile molecules (Effros et al. 2002). 
The mechanisms by which the smallest respiratory particles are 
transferred to the exhaled gases are not understood and further studies 
are required to better understand whether disease conditions may 
interfere with this process (Horvath et al. 2005). In humans, H2O2 
concentration and the pH of EBC have been evaluated in a large number 
of studies involving patients with various respiratory diseases and healthy 
controls. The concentration of H2O2 in EBC is well correlated to the 
presence of several respiratory diseases such as asthma, COPD, 
bronchiectasis and acute respiratory distress syndrome (ARDS) 
(Kietzmann et al. 1993; Jobsis et al. 1997; Jobsis et al. 1998; Loukides et 
al. 2002; Kostikas et al. 2003). Patients with asthma have higher 
concentrations of H2O2 in EBC compared to healthy individuals (Loukides 
et al. 2002). Asthmatic patients also have been shown to have higher 
concentrations of H2O2 in EBC during asthma exacerbation compared to 
periods of remission of the disease (Loukides et al. 2002). Studies of the 
pH of EBC have also been reported and provide a greater understanding 
of the involvement of airway acidification in the pathogenesis of lower 
airway inflammation (Loukides et al. 1998; Loukides et al. 2002; Vaughan 
et al. 2003; Borrill et al. 2005; Brunetti et al. 2006). 
  
Although many publications have described EBC collection, few studies 
have assessed methodological factors that may affect EBC collection and 
analysis. Methods of collection and analysis vary between studies and 
comparison of results between studies that do not use the same protocol 
is difficult. Differences in methods of collection, assays used for the 
determination of different substances and inter-lab variations due to the 
use of different equipment can all potentially bias the results and need to 
be described in detail in each study (Horvath et al. 2005). 
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2.2.1 Collection Methods: Bias and Limitations 
 
2.2.1.1 Human studies of exhaled breath condensate collection 
 
The American Respiratory Society/European Thoracic Society Task Force 
has developed guidelines for EBC collection and analysis of different 
biomarkers and have made recommendations for future developments 
(Horvath et al. 2005). The drafting of specific and strict guidelines for EBC 
collection was avoided, as the lack of validation studies hampered 
evidence-based recommendations (Horvath et al. 2005). Since the 
substances investigated in EBC have different biochemical structures and 
properties, different collection techniques may affect the half-life of 
different substances in the sample. Therefore, the choice of a particular 
methodology of collection should be guided by the biochemical properties 
of the substance of interest. Volatile substances, such as ammonia, tend 
to leave the sample soon after collection and need to be analysed 
immediately, while more stable substances, such as cytokines and 
arachidonic acid metabolites, can be frozen and stored for long periods of 
time without alteration in concentration (Horvath et al. 2005). 
One common factor between the different methodologies described in the 
literature is exhaled breath is directed by a one way flow into a collection 
system containing a condensation chamber kept at low temperature 
(usually -80˚C) that allows the condensation of the exhaled vapours in the 
breath and retention of the EBC in the condensation chamber. In human 
studies, several commercially available devices have been developed to 
improve the standardization of EBC collection. The RTubeTM (Respiratory 
Research Inc. VA) is a commercially available and disposable device that 
allows collection of EBC at home according to the patients’ schedule, or 
during exacerbations of respiratory disease when a sample may be more 
clinically significant. A mouthpiece is connected through a one-way valve 
directing exhaled breath into a polypropylene (PP) collection tube 
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surrounded by an aluminium sleeve cooled to -20˚C before collection. The 
circuit also contains a trap to avoid contamination of the sample with 
saliva. The patient breathes through the inlet one-way valve of the 
collection system for a pre-determined amount of time and then stores 
the sample obtained at <0˚C (i.e. in a domestic freezer with temperature 
of approximately -20˚C), until it is analysed. Studies that used this device 
to collect EBC have benefited from the feasibility of home collection 
making large population studies possible as well as frequent repeated 
collections from the same patients (Vaughan et al. 2003; Paget-Brown et 
al. 2006). A second available device is the ECoScreen (Jaeger, Wurzburg, 
Germany). With this device, exhaled breath enters and leaves the 
chamber through a one-way, non-rebreathing valve which prevents 
mixing of inspiratory and expiratory gases and filters saliva. This method 
uses an electrical refrigeration device that moves exhaled air through a 
lamellar condenser with a sample collection vial inserted into a cooling 
cuff. The interior temperature is constantly maintained at less than -15˚C.  
 
Since the RTubeTM and the ECoScreen are the most commonly used 
devices in published studies, a direct comparison between the two 
methods has been performed to determine whether results obtained are 
comparable (Soyer et al. 2006). The temperature in the condensation 
chamber of the ECoScreen was found to be more stable and lower than 
that of the RTubeTM. However, the main advantages of the RTubeTM, 
including transportability and low cost, make it useful for collection of EBC 
and analysis of the compounds in EBC that are minimally influenced by a 
rise in temperature. These advantages make this device suitable for use in 
studies of large populations. Another difference between these two 
devices is that the valve of the RTubeTM is made of silicone rubber 
whereas that of the lamellar condenser of the ECoScreen is made of 
aluminium coated with teflon. It has been suggested that some mediators, 
such as cytokines and other proteins, may be recovered more efficiently 
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from Teflon surfaces compared to silicon rubber, however little evidence is 
available to support this statement (Soyer et al. 2006; Prieto et al. 2007). 
 
Another device available commercially is the TURBO-DECCS (ItalChill, 
Parma, Italy) which has been used to study the effect of temperature of 
collection on the concentration of hydrogen peroxide in EBC of healthy 
individuals (Goldoni et al. 2005). The working temperature is adjustable 
from -10°C to room temperature or higher.  This system allows a very 
accurate control of the collection temperature and therefore is ideal for 
studies aimed at investigating the effect of temperature on concentration 
and stability of different substances collected within the EBC (Goldoni et 
al. 2005). 
 
The use of custom-made devices with a condensation chamber usually 
constituted of inert materials (either glass or Teflon), has been described 
by several authors (Kietzmann et al. 1993; Horvath et al. 1998; Mutlu et 
al. 2001; van Beurden et al. 2002b; De Benedetto et al. 2005). Although 
the results of these studies were similar to results of other studies using 
commercially available devices, it is possible that the unique nature of 
those systems may have influenced the results obtained or at least limited 
the repeatability of sample collection by other authors. 
 
Human EBC is collected through mouth expiration and most devices have 
been designed to prevent sample contamination with saliva. These 
systems are usually referred as saliva traps and are essential as 
production of saliva by some human patients can be marked. An accepted 
recommendation is to look for salivary contamination if a saliva trap is not 
utilized by measuring the salivary amylase (Effros et al. 2002). The use of 
nose clips to minimise contaminations of EBC samples with nasal 
secretions has been suggested by some authors, however there is 
insufficient data to currently support the use of these devices (Horvath et 
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al. 2005). Neither saliva traps or nose clips are applicable for collection of 
EBC from horses due to obligate nasal breathing in this species. 
 
Duration of EBC collection, contamination of the materials in contact with 
EBC and possible interactions between materials used and substances in 
the EBC sample are mandatory considerations when planning a study. The 
recommendation of the American Respiratory Society and of the European 
Thoracic Society is to record the duration of each collection and that this 
parameter should be set for each study protocol (Horvath et al. 2005). 
Furthermore, all materials that are in contact with EBC should be tested to 
exclude contamination of the sample that may confound results. The pH 
of EBC can be affected by contamination of the samples with saliva and 
the systems of collection and storage should be assessed to detect any 
salivary contamination (Horvath et al. 2005). 
 
2.2.1.2 Equine studies of Exhaled breath condensate collection 
 
Two devices have been described in the scientific literature for EBC 
collection from horses (Deaton et al. 2004b; Wyse et al. 2005). Between 
the two studies there were differences in equipment design. The device 
used by Deaton et al. (2004b) included a U-shaped stainless steel 
condensing tube that contained an inner volume of 5 litres. The 
condensing tube was immersed in ice and cold water to ensure a surface 
temperature for the condensation of EB of approximately 0°C. The tubing 
connecting the condensing tube to the horse was placed inside a larger 
and warmer pipe to keep the temperature in the inner pipe at a 
sufficiently high temperature to avoid condensation in the connecting pipe 
and maximize sample retrieval. Collection of EBC from horses was 
obtained by a modified AeroMask (Equine AeroMaskTM, Trudell Medical 
International, Veterinary Division, London, Ontario, Canada) that included 
a rubber shroud to provide an airtight seal on the face of the horse and a 
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one-way valve at the attachment of the connecting pipe to the 
condensation pipe. Wyse et al. (2005) used a Pyrex glass condensation 
chamber immersed in liquid nitrogen/ethanol slurry to create a much 
colder environment (<-80°C) for the collection of EBC than that used by 
Deaton et al. (2004b). Collection of EBC was obtained through a face 
mask sealed with a rubber shroud on the muzzle of the horse and 
unidirectional airflow was obtained with a non-rebreathing valve. The 
connecting pipes were made of rubber but were not warmed, to increase 
the portability of the device. Differences in equipment and temperature 
used for EBC collection and between the studies of Deaton et al. (2004b) 
and Wyse et al. (2005) limit the comparison of the results of these two 
studies.  
 
2.2.2 Hydrogen Peroxide Concentration in Exhaled Breath 
Condensate 
 
Of the substances present in EBC, hydrogen peroxide has been studied 
most extensively. In the respiratory system, H2O2 is thought to be 
produced by inflammatory cells (predominantly neutrophils, macrophages 
and eosinophils) and epithelial cells in the conducting airways (Schleiss et 
al. 2000). A relationship between H2O2 concentration in EBC and the 
presence and severity of respiratory diseases in humans including asthma, 
chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic 
fibrosis and pulmonary effects of smoking has been established (Jobsis et 
al. 1997; Horvath et al. 1998; Jobsis et al. 1998; Loukides et al. 1998; 
Kostikas et al. 2003).  
 
Differences in number and activation of inflammatory cells in the lower 
airways may explain the reported relationship between H2O2 and disease 
severity. Several studies have been performed in an attempt to identify 
which specific cell types produce H2O2 and the site of production in the 
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airways of humans with various diseases of the lower respiratory tract 
(Kietzmann et al. 1993; Montuschi et al. 2001; Nowak et al. 2001; Effros 
et al. 2002). Flow dependency of H2O2 concentration in EBC has been 
demonstrated in healthy and mildly asthmatic humans suggesting that 
production of H2O2 also occurs in the conducting airways and not only 
from the distal airways (Jobsis et al. 1997). The consistent increase in 
H2O2 concentration at lower respiratory flow rates supports the suggestion 
that there is a major bronchial contribution in addition to alveolar 
production (Schleiss et al. 2000). Schleiss et al. (2000) concluded that if 
alveolar H2O2 concentration is high, H2O2 could be absorbed within the 
bronchi during expiration and consequently the amount of exhaled H2O2 
will decrease with decreasing flow rates. Therefore monitoring expiratory 
flows during collection of EBC may contribute to the interpretation of EBC 
H2O2 concentration (Schleiss et al. 2000; Horvath et al. 2005). 
 
2.2.2.1 Usefulness of measurement of EBC H2O2 in human 
medicine 
 
Hydrogen peroxide is commonly present in EBC obtained from healthy 
humans and concentrations are variable, depending on age and living 
habits. Elderly people have higher concentrations than young adults and 
healthy children, but lower concentrations than smokers and ex-smokers. 
Patients with pulmonary disease including COPD (van Beurden et al. 
2002a), bronchiectasis (Loukides et al. 1998) and acute respiratory 
distress syndrome (ARDS) (Kietzmann et al. 1993) have statistically 
significantly higher H2O2 concentrations in EBC compared to controls. 
Children and adults with asthma have a greater concentration of EBC H2O2 
than healthy individuals (Jobsis et al. 1997; Horvath et al. 1998). Further, 
a correlation with the severity of disease in asthmatic humans has been 
described; EBC H2O2 concentrations increase during exacerbations of the 
disease, while clinical improvement usually leads to a decrease in EBC 
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H2O2 concentration (Loukides et al. 2002). Conversely, studies of patients 
with cystic fibrosis failed to demonstrate increased concentrations of H2O2 
in EBC. This is possibly due to the degradation of the majority of H2O2 
through reaction with viscous airways secretions or other reactive species 
or increased antioxidant activity caused by trapping of positively charged 
antioxidants in negatively charged airways secretions (Ho et al. 1999). 
The use of other markers in EB, for example CO is more appropriate in the 
investigation of cystic fibrosis (Kharitonov and Barnes 2002). 
 
The potential usefulness of EBC in monitoring the effect of treatment in 
patients with respiratory disease has been investigated. In mildly 
asthmatic patients a relationship between H2O2 concentrations and 
response to treatment with corticosteroids have been documented, 
whereby a treatment with inhalatory HFA-beclomethasone for 4 weeks 
significantly decreased EBC H2O2 concentrations for a period of at least 
two weeks after the discontinuation of the medication concurrent with 
remission of symptoms (Antczak et al. 2000). In patients with clinically 
stable COPD, treatment with N-acetylcysteine produced similar results, 
significantly reducing EBC H2O2 concentration after only 15 days of 
treatment (Kharitonov and Barnes 2004; De Benedetto et al. 2005). 
 
While considerable advances in the analysis of EBC and EB obtained from 
humans has occurred over the last decade, these methodologies and 
analytes are not considered suitable for sole monitoring of patients with 
respiratory disease and further data are warranted to better understand 
the potential of these tests in human respiratory medicine (Horvath et al. 
2005). The applicability of these methodologies in routine clinical settings 
is still limited. Studies on the physiology of EBC formation and its dilution 
markers and improvements in the reproducibility of these tests are still 
warranted before they can substitute more traditional methods in the 
management of individual patients (Horvath et al. 2005). 
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2.2.2.2 Limitations of measurement of EBC H2O2
 
Although several authors have outlined the potential of determination of 
EBC H2O2 concentration for use in human respiratory medicine (Jobsis et 
al. 1997; Horvath et al. 1998; Loukides et al. 1998; Kostikas et al. 2003) 
and to a lesser degree in horses (Deaton et al. 2004b; Wyse et al. 2005), 
measurement of H2O2 is not without certain considerations. Being a free 
radical, H2O2 is a very reactive molecule that can undergo rapid 
degradation during interaction with different materials (Horvath et al. 
2005). Because of this instability, samples of EBC must be analysed 
immediately or frozen and stored at temperatures ≤-70˚C until analysis of  
H2O2 concentration (Horvath et al. 2005). 
 
In humans, the concentration of H2O2 is up to 100 fold greater in saliva 
than in EBC and it is therefore mandatory to exclude any salivary 
contamination of obtained EBC to ensure the sample is representative of 
the lower respiratory tract (Horvath et al. 2005). Many of the devices used 
for collection of EBC from humans in previously published studies 
contained saliva traps to avoid sample contamination (Horvath et al. 
2005). Alternatively, EBC samples from humans may be collected during 
nasal respiration to exclude contamination with saliva, however H2O2 
concentrations are not comparable with those obtained by oral collection 
(Latzin et al. 2003). 
 
The laboratory method used for determination of H2O2 concentration in 
EBC can influence the obtained results. Many methods for measurement 
of H2O2 concentration have been reported and the physiological 
concentrations of EBC H2O2 are often very close to, or even less than, the 
lower detection limit of many of these assays (about 0.1 µm/L) (Gallati 
and Pracht 1985; van Beurden et al. 2002b; Svensson et al. 2004). 
Colorimetric or fluorimetric assays are most commonly used. Automated 
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fluorimetric assays are most accurate and precise and have detection limit 
of 0.005 µm/L (van Beurden et al. 2002b). An automated flow injection 
analysis with fluorescence detection has similar detection limit (40nm/L) 
but these methods require the use of equipment with limited availability 
(Svensson et al. 2004).  
 
For any diagnostic test, a large coefficient of variation for repeated 
measurements makes comparison of data within and between studies 
difficult. Assessment of variation of H2O2 concentration in EBC of human 
patients has been performed by determining both the intra-day and inter-
day coefficient of variation (CV) of EBC H2O2 concentration using repeated 
sample collection from the same patients (van Beurden et al. 2002a). In 
the study of van Beurden (2002a) analysis of three samples of EBC 
collected on the same day from healthy non-smoking individuals revealed 
an intra-day coefficient of variation (CV) of H2O2 concentration that was 
approximately 20%. In addition, the inter-day CV from four samples 
collected over a period of 21 days was 43% (van Beurden et al. 2002a). 
The same protocol was used also in a group of patients with clinically 
stable COPD and the calculated CV were similar to the control group 
(approximately 24% and 45% for intra-day and inter-day repeated 
measurements respectively) (van Beurden et al. 2002a). A significant and 
repeatable increased production of H2O2 at 12am and 12pm was also 
described and was interpreted by the authors as circadian variation (van 
Beurden et al. 2002a). 
 
Nowak et al. (2001) assessed diurnal variations in H2O2 concentration in 
EBC using a protocol similar to that described by van Beurden et al. 
(2002a). Intra-day variation in H2O2 concentration was assessed by 
collecting four samples of EBC in a single day from 58 healthy volunteers 
and inter-day variation was determined by collection of three further 
samples every seven days during two consecutive weeks from the same 
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individuals. In that study, EBC H2O2 concentrations were greater at 12 am 
and 12 pm and lower at 8 am and 8 pm. This variation was considered to 
be dependent on diurnal variation in leukocyte receptors and circulating 
concentrations of adhesion molecules, changes in antioxidant enzyme 
activity or differing concentrations of low molecular weight antioxidants in 
epithelial lining fluids (Nowak et al. 2001).  
 
The duration of EBC collection has been studied as a possible cause for 
variability in H2O2 concentration, however no significant difference in EBC 
H2O2 concentration was found when samples obtained over a collection 
period of 4 or 10 minutes from human patients were compared (Svensson 
et al. 2004). 
 
To date none of the published studies of EBC collection from horses 
(Deaton et al. 2004b; Wyse et al. 2005) determined intra-day and inter-
day variations in H2O2 concentration, or the effect of duration of collection 
on H2O2 concentration. 
 
2.2.3 Exhaled Breath Condensate pH 
 
Exhaled breath condensate pH is considered to reflect the acid-base 
balance status of the airways and can be easily measured in samples 
obtained from human patients. The normal homeostasis between acid and 
basic buffer systems is the result of balanced production and release of 
acids and bases in the airways. Changes in airway pH have been 
associated with many pathological events and a low pH of EBC is thought 
to be a consequence of inflammation in the airways (Kostikas et al. 2002). 
Airway acidification has been implicated in the pathophysiology of asthma 
as it accelerates necrosis of human eosinophils and the conversion of 
endogenous nitrites to NO (Hunt et al. 2000). Exhaled breath condensate 
pH values have been found to be identical to those obtained from lower 
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airway secretions, thus reflecting the acidification in the lower respiratory 
tract (Hunt et al. 2000). However, it is not entirely understood if 
endogenous acidification is an unequivocal indicator of the presence of 
inflammation in the airways (Hunt et al. 2000). A reduction in airway pH 
has been shown to induce bronchoconstriction, impairment of ciliary 
motility, increased mucus viscosity and damage to airway epithelium. 
Measurement of EBC pH is usually obtained using bench pHmeters that 
have high accuracy and are sensitive to changes of ±0.01 pH units 
(Horvath et al. 2005). Blood gas analysers with similar accuracy have also 
been used recently (Kullmann et al. 2007). 
  
2.2.3.1 Usefulness of measurement of EBC pH in human medicine 
 
As with many other physiologic variables, pH in EBC has been studied 
widely in order to understand how it is influenced by respiratory diseases. 
The pH of samples from patients with asthma, COPD, bronchiectasis and 
healthy controls have been measured, to establish the magnitude of 
change occurring in these diseases (Hunt et al. 2000; Tate et al. 2002; 
Borrill et al. 2005; Horvath et al. 2005; Brunetti et al. 2006). Correlation 
between EBC pH and a variety of inflammatory airway conditions in 
humans has been shown, including eosinophilic and neutrophilic 
inflammation in induced sputum (Kostikas et al. 2002). While the pH of 
EBC from patients with mild asthma was not different from that of healthy 
controls, more severe forms of the disease induced a significant decrease 
in pH (Kostikas et al. 2002). The same authors reported that in general, 
patients with bronchiectasis complicated by chronic infections with 
Pseudomonas aeruginosa had lower pH values than asthmatic patients 
(Kostikas et al. 2002). However, Hunt et al. (2000) reported that the 
lowest EBC pH values were in samples from patients with acute episodes 
of asthma. In another study, children with allergic rhinitis and/or atopic 
dermatitis had an EBC pH lower than healthy controls and it was 
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suggested that the more acidic environment in the lower airways of these 
patients could predispose to development of asthma and monitoring of 
EBC pH could be useful for early detection of this condition (Brunetti et al. 
2006). 
 
The relationship between lower airway inflammation and EBC pH is 
indicated further by the finding that inhalatory corticosteroid therapy in 
human patients with LAI results in an increase in the pH of EBC (Hunt et 
al. 2000). Hence measurement of the pH of EBC may be useful to monitor 
patients receiving treatment with corticosteroids in a non-invasive 
manner, as a decrease in activity of inflammatory cells and reduced 
production of molecules that can induce acidification in the lower airways 
would be expected (Kostikas et al. 2002; Horvath et al. 2005; Brunetti et 
al. 2006). 
 
Acidification of EBC in patients with cystic fibrosis has been recorded, 
likely due to reduced excretion of buffers (eg. bicarbonates) in the lower 
airways (Tate et al. 2002). Airway acidification may be important in the 
pathogenesis of this disease, as it may reduce ciliary function, increase 
mucus viscosity and impair some humoral immune mechanisms (Tate et 
al. 2002). 
 
A large study of healthy non-smoking human patients was performed to 
assess the intra-weekly and intra-daily variations in EBC pH and whether 
different methodologies of collection could bias the data (Vaughan et al. 
2003). The CV for intra-week and intra-day repeated measurements in 
that study were 4.5% and 3.5%, respectively. Collecting at different 
temperatures, collection times and ventilatory patterns did not 
significantly alter the pH in the samples obtained. Furthermore, storage 
for prolonged periods of time (>12 months) had a minimal effect on the 
CV of pH measurement (3%). The pH of EBC has been found to be very 
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similar before and after induction of general anaesthesia in human 
patients scheduled for elective surgical procedures (Wells et al. 2005). In 
that study collection of exhaled breath samples was achieved through a 
cuffed tracheal tube, therefore bypassing the upper respiratory tract. In 
EBC obtained from healthy human patients the pH is slightly alkaline and 
within a narrow range (Wells et al. 2005). The findings of Wells et al. 
(2005) and other studies (Vaughan et al. 2003; Borrill et al. 2005; 
Bloemen et al. 2006) indicate that EBC pH is a simple, robust and 
reproducible indicator of acidification in the lower airways. 
 
2.2.3.2 Limitations of measurement of EBC pH  
 
The pH of EBC tested immediately after sampling from healthy human 
subjects tends to be unstable and obtained measurement may be 
unreliable (Kullmann et al. 2007). To reduce the instability of EBC pH, 
attempts have been made to stabilize the samples of EBC. Carbon dioxide 
is one of the main contributors to pH instability in EBC and is the major 
volatile component of EBC (Kullmann et al. 2007). In an aqueous 
environment, CO2 reduces the pH by forming H+ and HCO3- through the 
chemical reaction: H2O+CO2<=>H2CO3<=>H++HCO3-. Procedures to 
remove CO2 from EBC are referred to as deaeration or gas-standardization 
and are achieved by bubbling a CO2-free gas through the sample for a set 
time period (Kullmann et al. 2007). The rationale for deaeration of EBC is 
to control the variation resulting from the interaction between EBC and 
the atmosphere. Argon is reported to be used most frequently, as it is a 
noble gas and is unlikely to interact with any of the endogenous 
substances in the sample (Horvath et al. 2005). Alternatively, nitrogen or 
oxygen have been used for gas-standardisation (Horvath et al. 2005). 
Some authors have preferred to measure the pH of EBC immediately after 
collection without any deaeration (Tate et al. 2002; Bloemen et al. 2006). 
Deaeration of EBC samples obtained from healthy humans and humans 
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with asthma using argon resulted in good repeatability of pH 
measurements, with CV of approximately 3.3% for both groups (Hunt et 
al. 2000). Furthermore, deaerated samples had values of pH identical to 
EBC samples suctioned directly from the lower airways (Vaughan et al. 
2003). In human patients with COPD undergoing mechanical ventilation, a 
close relationship between pH measurements before and after Argon 
deaeration has been reported (Gessner et al. 2003). However, other 
authors have shown that the effect of gas standardisation is unpredictable 
for samples with an initial pH lower than 6, possibly due to inefficient 
removal of CO2 or to the presence of strong acids in the EBC. Complete 
removal of CO2 is not possible as a residual amount is always present 
after deaeration, potentially confusing pH assessment (Borrill et al. 2006; 
Horvath et al. 2006).  
 
Recently, a study of the effect of CO2 partial pressure on EBC pH was 
reported (Kullmann et al. 2007). This procedure consisted of preparing the 
EBC samples with CO2, achieved by bubbling CO2 in the sample for 1 
second and then pH and EBC CO2 partial pressure (PEBC,CO2) were 
measured with a blood gas analyser. The data obtained were used to 
calculate the value of the pH at 5.33 kPa PEBC,CO2 (physiological PEBC,CO2) in 
the lower airways by data regression analysis. Because this methodology 
accounted for the variability of the pH measurement due to the variable 
amount of CO2 present in the sample, results were approximately six times 
more repeatable than deaeration with argon (Kullmann et al. 2007). 
Further investigations are required to validate the methodology; however 
the study of Kullmann et al. (2007) proved that CO2 has a major role in 
influencing EBC pH. 
 
Other influences on the pH measured from EBC samples include 
contamination with endogenous substances of oral origin and patient 
activity. While contamination of EBC samples with ammonia from the oral 
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cavity has been suggested to influence EBC pH there is little evidence that 
it interferes with the total EBC pH (Effros et al. 2003; Horvath et al. 
2005). Recently, moderate exercise was shown to induce an increase of 
pH in healthy patients compared to the pre-exercise values (Riediker and 
Danuser 2007). Therefore exercise may affect the sensitivity of EBC pH by 
masking the acidification induced by an ongoing inflammatory process 
(Riediker and Danuser 2007) and has ramifications for timing of EBC 
sample collection from patients in relation to exercise. 
 
2.3 Lower Airway Inflammation in Horses 
 
Disorders of the lower respiratory tract are common in horses and can 
affect animals of all ages and breeds. Presenting complaints may include 
exercise intolerance, cough, nasal discharge, fever, respiratory distress 
increased respiratory rate or effort, signs of depression or inappetence. 
Diseases that can affect the airways and/or the parenchyma of the lungs 
include bacterial, viral, parasitic or fungal pneumonia, lung abscess, 
pleuropneumonia, acute respiratory distress syndrome (ARDS), pulmonary 
oedema, exercise induced pulmonary haemorrhage (EIPH), interstitial 
lung disease, recurrent airway obstruction (RAO), summer pasture-
associated recurrent airway obstruction (SPA-RAO), inflammatory airway 
disease (IAD), smoke inhalation and neoplasia. These diseases are 
associated with inflammation of the lower airways and/or lung 
parenchyma and different mechanisms are involved dependent on 
aetiology and disease process. Recurrent airway obstruction, SPA-RAO 
and IAD involve specific and/or non-specific immune responses to 
antigens that enter the lower airways through inhalation. These diseases 
are collectively referred to as lower airway inflammation (LAI) in this 
thesis. Clinical signs of lower airway disease are not specific and a 
definitive diagnosis is frequently difficult to achieve on clinical examination 
alone. The use of ancillary diagnostic techniques including endoscopy, 
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tracheal aspirate cytology, bronchoalveolar lavage (BAL) cytology, thoracic 
radiography, ultrasonography, arterial blood gas analysis, pulmonary 
function testing may provide information on the ongoing process, 
contribute to obtaining a definitive diagnosis and provide information on 
disease severity. Further, these tests may provide evidence of the 
pathophysiology of different disease processes that affect the lower 
airways (Ainsworth and Hackett 2004). 
 
Lower airway inflammatory disorders of horses have important 
implications for the horse industry. Diseases such as RAO, SPA-RAO or 
pneumonia can be invaliding and cause obvious poor performance and 
loss of athletic potential and premature retirement from athletic activities 
(Robinson 2001). While other pulmonary diseases may not result in any 
clinical abnormalities or rest (eg. IAD, EIPH), impaired lung function 
during exercise may result in exercise intolerance or poor performance 
(Hinchcliff et al. 2005; Couetil et al. 2007). 
 
2.3.1 Recurrent Airway Obstruction (Heaves) 
 
Recurrent airway obstruction is a common inflammatory disease of the 
lower airways of mature horses (Dixon et al. 1995a; Robinson 2001). 
Although there are many studies describing the clinical signs attributable 
to RAO, the relationship between causal factors, structural changes, 
airway hyper-reactivity and airway inflammation remain incompletely 
understood. Recurrent airway obstruction is characterised by reversible 
airway narrowing due to bronchospasm that is exacerbated by mucosal 
hypertrophy and intraluminal secretions. The most frequent clinical sign of 
RAO is cough that can occur during/after exercise, or after exposure to 
triggering factors contained in mouldy hay or dusty environments. Many 
horses with RAO also have a mucous to mucopurulent bilateral nasal 
discharge. The respiratory pattern of affected horses can also change as 
 28
bronchospasm increases the resistance to the airflow in the distal airways, 
principally during expiration. With protracted disease, hypertrophy of 
abdominal muscles subsequent to the increased respiratory effort may 
occur resulting in the characteristic heave line, from which the name 
“heaves” is derived. For many years RAO has been compared to human 
asthma because of common features such as airway hyper-responsiveness 
and reversible airway narrowing. Cytologically one difference between 
RAO and asthma is neutrophils are the dominant cell type of the epithelial 
lining fluids of the lungs in RAO while eosinophils may predominate in 
human asthma. Previously RAO was referred to as chronic obstructive 
pulmonary disease (COPD), a term derived from human respiratory 
medicine. However, many differences are recognized between RAO and 
human COPD, the latter being a progressive disease with little or no 
reversibility of airway constriction, often related to smoking habits. 
Currently the accepted terminology is recurrent airway obstruction (RAO) 
know also as “heaves” or “broken wind” (Robinson et al. 2003). The 
microscopic anatomy of the airways in horses with RAO has been 
described in detail using light and electron microscopy (Kaup et al. 1990a; 
Kaup et al. 1990b; Pirie et al. 1990). Principal abnormalities of the alveolar 
region include focal necrosis of type I epithelial cells, fibrosis, type II 
epithelial cell transformation and emphysema with hyperinflation (Kaup et 
al. 1990a). Necrotic foci are usually located in the peribronchiolar region. 
In the bronchiolar epithelium, the non-ciliated bronchiolar epithelial cells, 
known also as Clara cells, are the cell type that show the most significant 
ultrastructural degeneration (Kaup et al. 1990a). Metaplasia of the mucus 
secreting cells (goblet cells) in the lower airway epithelium of horses with 
RAO has also been described (McPherson and Thomson 1983; Nyman et 
al. 1991). Bronchiolitis, airway smooth muscle hypertrophy, excess mucus 
and inflammatory cells in the small airways are commonly present in 
horses with RAO and likely contribute to airway narrowing ante-mortem 
(Kaup et al. 1990a). Macroscopically, the lungs of horses with RAO may 
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appear hyperinflated and indentations may be present due to the pressure 
on the thoracic cage in advanced cases (Kaup et al. 1990a). In the larger 
conducting airways, epithelial cell hyperplasia, loss of ciliated cells, mucus 
accumulation due to decreased clearance, goblet cell hyperplasia and 
infiltration of neutrophils, eosinophils and mast cells may be present 
(Kaup et al. 1990b). 
 
Much attention has been directed toward the etiopathogenesis of RAO and 
postulated causes include specific immune-mediated responses to fungal 
antigens and non-specific inflammatory responses to inhaled pro-
inflammatory agents including moulds, endotoxins, particulate and 
noxious gases which are present in the breathing zone of stabled horses 
(McPherson et al. 1979; McGorum and Dixon 1993; McGorum et al. 
1993a, d; McGorum et al. 1998; Schmallenbach et al. 1998; Pirie et al. 
2001; Pirie et al. 2002, 2003; Ward and Couetil 2005). Clinical signs of 
RAO can be induced by exposure of susceptible animals to dusty and 
mouldy hay and it has been postulated that RAO is an allergic (type I 
and/or type III and type IV hypersensitivity) reaction to Faenia rectivirgula 
(Micropolyspora faeni), Aspergillus fumigatus and/or Thermoactinomyces 
vulgaris, which are abundant in poor quality hay (McGorum et al. 1993d). 
McGorum et al. (1993d) reproduced signs of RAO in susceptible horses 
after exposure to these fungal antigens, supporting the theory that these 
antigens play a role in RAO pathogenesis. A classic allergic response 
following exposure to these agents can be biphasic as demonstrated in 
humans with allergic airway disease (Durham et al. 1984). Similarly to 
humans, in horse with RAO “early-phase response” starts within minutes 
from exposure to specific antigens with the activation of mast cells with 
membrane bound allergen-specific immunoglobulin (IgE) (Halliwell et al. 
1993). Activated mast cells release pro-inflammatory mediators including 
histamine that stimulate mucus secretion, vasodilatation, microvascular 
leakage and airway smooth muscle contraction. Immunoglobulin E is more 
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abundant in bronchoalveolar secretions of horses with RAO compared to 
controls, however no differences are present in serum concentrations 
(Halliwell et al. 1993), suggesting that any allergic response is confined 
predominantly to the lower airways. In humans with asthma the early 
phase response of the disease induces narrowing of the airway lumen and 
obstruction of airflow within 1 hour from the initial exposure to the stimuli. 
However, the early-phase response is clinically silent in horses with RAO 
(Robinson 2001). The ‘late-phase response’ occurs later after exposure to 
aeroallergens because of slower chemotactic recruitment of neutrophils 
coordinated by T cells through the release of Th2-type cytokines and 
chemokines. The absence of the early phase response in horses with RAO 
suggest that a classical type I hypersensitivity is not the central pivot in its 
pathogenesis. Some authors have postulated that a type III 
hypersensitivity (Arthus) reaction may be involved in the pathogenesis of 
RAO, namely a response to an allergen to which the immune-system had 
been previously sensitised (Halliwell et al. 1979), however the lack of 
precipitating serum antibodies toward the allergens has lead to a dismissal 
of this hypothesis (Lawson et al. 1979). 
 
Respirable endotoxins have been implicated in the pathogenesis of RAO 
and a dose-dependent neutrophilia after inhalation of endotoxin in healthy 
horses and horses with RAO has been reported (Pirie et al. 2001). After 
inhalation of endotoxin, both healthy horses and those with RAO had a 
significantly increased lower airway neutrophilia, however worsening of 
clinical signs was not observed. The airway neutrophilia of horses with 
RAO was significantly greater in magnitude that that in healthy horses, 
(Pirie et al. 2001). The lack of clinical signs after challenge with inhaled 
endotoxin suggests that endotoxins are not the only causative agent and 
involvement of other agents in the pathogenesis of the disease is likely. 
Moulds and hay dusts have a higher content of β–D-glucan, and are more 
likely to induce exacerbation of RAO (Pirie et al. 2002). It has been 
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suggested that endotoxin, β–D-glucans and organic dust particles such as 
fungal antigens have a synergistic pro-inflammatory involvement in the 
pathogenesis of RAO (Pirie et al. 2003). In addition, noxious gases such 
as ammonia, hydrogen sulphide and methane have been suggested to 
induce airway inflammation; despite very low ambient concentrations of 
these gases, it is possible that horses with RAO are more susceptible 
(Clarke 1987; Clarke et al. 1987). 
 
Bronchospasm is a key feature in RAO, since improvement of clinical signs 
and pulmonary function can be induced after administration of 
bronchodilators (Jackson et al. 2000). Bronchospasm is mediated by 
airway smooth muscle contraction likely activated by stimulation of 
parasympathetic tone and activation of muscarinic receptors. In addition, 
inflammatory mediators such as serotonin, endothelin-1, histamine and 
LTD4 can increase the contractility of smooth muscle cells directly and 
may contribute to bronchoconstriction in horses with RAO. Further, 
decreased activity of the inhibitory, non-adrenergic, non-cholinergic neural 
pathways is thought to contribute to the lack in bronchorelaxation 
(Robinson 2001).  
 
Airway neutrophilia is the main cytological feature of RAO and large 
numbers of neutrophils can accumulate in the lower airways within 6 
hours after exposure to mouldy hay (Pirie et al. 2001). However, the 
details of the mechanisms responsible for neutrophil activation and 
recruitment remain poorly understood (Pirie et al. 2001). Interleukin-8 (IL-
8) is one of the most potent neutrophil-specific chemotactic and activating 
protein, and an increase in IL-8 is present in horses with RAO after 
environmental challenge, suggesting the importance of this 
chemoattractant in RAO pathophysiology (Franchini et al. 2000). 
Neutrophils can also produce and secrete pro-inflammatory cytokines such 
as myeloperoxidase, TNF-α, IL-1β, IL-6, MIP-2 and IL-8 which have 
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chemotactic properties that can further exacerbate the inflammatory 
process (Joubert et al. 2001; Art et al. 2006). In healthy horses and 
horses with RAO in remission that are stabled at pasture, mRNA 
expression of IL-8 is down-regulated compared to the same horses with 
RAO during exacerbation of the disease (Joubert et al. 2001). In healthy 
stabled horses, bronchoalveolar neutrophilia may occur in the absence of 
clinical signs, suggesting that in these animals neutrophils may be in a 
reduced state of activation (Art et al. 2006). In the study reported by Art 
et al. (2006) healthy horses had similar neutrophil ratios but significantly 
lower myeloperoxidase concentration in BALF compared to horses with 
RAO in remission. 
 
Lymphocytes, specifically T cells, also contribute to the secretion of 
cytokines. The T-helper type 2 lymphocytes (Th2) are believed to play a 
central role in allergic airway inflammation, producing interleukin 4 (IL-4), 
IL-5, IL-9 and IL-3. Interleukin 4 induces the proliferation and 
differentiation of both B and T cells, IL-5 is involved in the activation of 
eosinophils, IL-9 stimulates the production of immunoglobulins and mast 
cells and IL-13 stimulates the growth of B cells and their production of 
immunoglobulins, production of other interleukins and inhibits T-helper 
type 1 lymphocytes (Th1) cells. Conversely Th1 are involved in cell-
mediated immunity, releasing interferon (IFN)-γ and IL-2, cytokines that 
stimulate the growth and differentiation of T cells and release of other 
cytokines (Lavoie et al. 2000; Beadle et al. 2002; Cordeau et al. 2004; 
Kleiber et al. 2005). It is believed that a balance between Th1 and Th2 
responses is important for the modulation of airway inflammation, and the 
expression of mRNA of Th1 and Th2 cytokines in healthy horses and 
horses with RAO has been investigated (Lavoie et al. 2000; Beadle et al. 
2002). In human asthma, expression of a Th2-type cytokine response is 
predominant and it has been postulated that similar process may occur in 
RAO (Lavoie et al. 2000). In horses with RAO increased expression of IL-4 
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mRNA in leukocytes is associated with worsening of clinical signs (Cordeau 
et al. 2004). Interleukin 4 promotes the development of a Th2 cell 
dominated immunoresponse and the induction of production of IgE by B-
cells (Lavoie et al. 2000; Beadle et al. 2002; Cordeau et al. 2004). 
However, several studies have provided divergent results and it is still not 
clear whether RAO results predominantly from a Th-1, Th-2 or mixed Th-
1/Th-2 disorder (Ainsworth et al. 2003). 
 
Macrophages are also likely to be involved in the pathogenesis of RAO. In 
RAO affected horses, these cells are more active, with a higher density in 
the distal airways and therefore may be able to produce more pro-
inflammatory mediators to attract neutrophils and stimulate epithelial 
cells, smooth muscles and goblet cells (Derksen et al. 1988; Ainsworth et 
al. 2003; Laan et al. 2005; Laan et al. 2006).  
 
Another characteristic feature of RAO is abnormal mucus production. 
Goblet cell hyperplasia and metaplasia may result in an increase in 
viscosity of mucin, occlusion of the lumen of the smaller airways, 
decreased cough and mucociliary clearability indices and exacerbation of 
lower airway obstruction (Dixon et al. 1995c; Gerber et al. 2000). Altered 
visco-elasticity of mucus in horses with RAO likely contributes to stasis 
and accumulation of mucus in the lower airways (Gerber et al. 2000). 
Large amounts of mucus can accumulate in the peribronchiolar alveoli and 
mineralise. These findings are related to the severity of the clinical signs 
and are more frequent and extensive in more advanced processes and 
contribute to the irreversible and progressive decline of the respiratory 
function in affected individuals (Robinson 2001; Lavoie 2007).  
 
The chronic nature of the inflammatory process in RAO may induce 
structural changes in the airways linked to smooth muscle hypertrophy 
and bronchiectasis. This increased smooth muscle mass induces not only 
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narrowing of the lower airways but also a stronger contraction of those 
muscles, further contributing to bronchospasm (Lavoie 2007). 
 
2.3.2 Summer Pasture-Associated Recurrent Airway Obstruction  
 
Summer pasture-associated recurrent airway obstruction (SPA-RAO) is a 
respiratory disease characterised by lower airway inflammation, recurrent 
airway obstruction and respiratory distress. The disease is most common 
in the southern regions of the United States, however it has been reported 
also in the UK (Dixon et al. 1995b; Mair 1996). The etiopathogenesis of 
SPA-ARAO is not understood completely; however, hypersentivity to 
aeroallergens is considered likely and the disease may share several 
immunological similarities with RAO. Indeed recurrent airway obstruction 
and SPA-RAO are not mutually exclusive and horses may be affected by 
both conditions (Dixon et al. 1995a; Mair 1996). Summer pasture-
associated recurrent airway obstruction occurs in horses kept at pasture 
and aerosolised spores and pollens have been incriminated as aetiological 
factors that precipitate hypersensitivity reactions in the lower airways 
(Ward and Couetil 2005). Summer pasture-associated recurrent airway 
obstruction has marked seasonality; prevalence of disease is most 
frequent during the summer months (Mair 1996). Removing affected 
animals from pasture during summer months and housing in a dust free 
environment in stables can reduce the reoccurrence and severity of the 
disease (Beadle 1983). Relationships between the prevalence of SPA-RAO 
and rainfall, minimum temperature and total pollen and mould counts in 
the environment have been documented, suggesting that these 
environmental factors may contribute to the occurrence of the disease 
(Ward and Couetil 2005). Epidemiological studies have shown an 
association of occurrence of SPA-RAO and total pollens counts of Quercus, 
Fraxinus, Morus and Acer spp. during the previous 3 months and fungal 
spores of Alternaria spp and Cladosporium spp. during the previous month 
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in the area where the affected horses lived (Ward and Couetil 2005). 
However, no increased concentration of pollen specific antibodies in the 
tracheal secretions of affected horses with SPA-RAO were found in one 
study and the authors postulated that the disease derives from the 
ingestion of a pasture derived pneumotoxin (Seahorn et al. 1997). Nitric 
oxide may possibly play a role in amplifying the inflammatory process 
since the expression of the nitric oxide synthase (iNOS) was greater in 
bronchial epithelial cells in horses with SPA-RAO compared to healthy 
subjects (Costa et al. 2001). 
 
The pathological features in horses with SPA-RAO are accumulation of 
mucus, accumulation of degenerated and sloughed epithelial and 
inflammatory cells (mostly neutrophils) in airway secretions and smooth 
muscle hypertrophy. Unlike RAO, fibrosis and emphysema are not 
prominent features of SPA-RAO (Costa et al. 2000). 
 
2.3.3 Inflammatory Airway Disease (IAD) 
 
Inflammatory airway disease (IAD) is a poorly understood condition and 
controversy exists over the definition of this disease. Inflammatory airway 
disease is typified as a syndrome characterised by cough, accumulation of 
secretions in the trachea, nasal discharge, poor exercise performance and 
delayed recovery from exercise (Couetil et al. 2007). Cytological 
examination of BALF from horses with IAD demonstrates airway 
inflammation most typically neutrophilic, however increased percentages 
of eosinophils and/or mast cells may be present (Moore et al. 1995). 
Inflammatory airway disease is not characterised by increased respiratory 
effort, systemic illness or haematological or serum biochemical 
abnormalities. One study found numbers of CD8-positive lymphocytes 
were increased in BALF from horses with IAD, in contrast with horses with 
RAO which had CD4-positive lymphocytes (Moore et al. 1995). The 
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authors concluded that these findings support the theory that IAD does 
not have an allergic aetiology but is possibly linked to a response to 
environmental factors or to an infectious agents.  
Recently, a consensus statement of the American College of Veterinary 
Internal Medicine proposed the use of the following minimum criteria to 
define IAD (Couetil et al. 2007):  
- Poor performance, exercise intolerance, or coughing, with or without 
excess tracheal mucus. 
- Non septic inflammation detected by cytologic examination of 
bronchoalveolar lavage fluid (BALF) or pulmonary dysfunction based on 
evidence of lower airway obstruction, airway hyper-responsiveness, or 
impaired blood gas exchange at rest or during exercise. 
These authors also proposed some exclusion criteria: 
- Evidence of systemic signs of infection (fever, hematologic abnormalities 
compatible with infection) 
- Increased respiratory efforts at rest (i.e., heaves) 
 
The etiopathogenesis of IAD is complex and not completely understood. 
Several authors have suggested that an infectious component may be 
involved (Christley et al. 2001; Wood et al. 2005; Christley and Rush 
2007; Couetil et al. 2007). Bacterial species isolated from horses with IAD 
include Streptococcus zooepidemicus, S. pneumoniae, S. suis, S. sanguis, 
Pasteurella spp., Bordetella bronchiseptica, Mycoplasma faelis and M. 
equirhinis. However, the role of bacteria in IAD remains undefined and it 
is possible that a primary inflammatory process may predispose to 
secondary colonization by oropharyngeal flora (Christley et al. 2001). 
Recently, Wood et al. (2005) found a statistical relationship between IAD 
and S. zooepidemicus and S. pneumoniae tracheal infections. In addition 
the prevalence and incidence of the disease decreased in older horses, 
suggesting that acquisition of immunity to bacteria may play a protective 
role (Wood et al. 2005). In horses infected by Dictyocaulus arnfieldi 
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airway eosinophilia may also be present and parasitic pneumonia is 
considered a differential diagnosis when BALF eosinophilia is present 
(Couetil et al. 2007). Little evidence exists to substantiate a role of viral 
infection in the pathogenesis of IAD. While one study found administration 
of the recombinant IFN-α (a cytokine with anti-viral properties) reduced 
respiratory tract inflammation in racehorses with IAD (Moore et al. 2004), 
other studies failed to detect seroconversion to equine herpes virus (EHV-
1 and EHV-4), equine rhinovirus (ERhV-1, ERgV-2), equine influenza virus 
or adenovirus (Christley et al. 2001) in horses with IAD.  
Non infectious causes have also been suspected to be involved in IAD 
etiopathogenesis. Horses of all ages may develop IAD, however it is more 
common in younger horses, especially racehorses in training and it has 
been suggested that exercise may be involved in the pathogenesis of the 
disease. It is possible that during strenuous exercise a greater deposition 
of particulate matter in the lower airways may be enhanced by frequent 
deep breathing (Christley and Rush 2007). In addition exercise may 
contribute to exposure of the lower airways to unconditioned air. In 
addition, disease is more likely to be detected in racehorses due to 
detection of poor performance. Inhaled endotoxins may play a role in the 
etiopathogenesis of IAD. Malikides (2003) found that exposure to 
respirable endotoxin can induce pulmonary inflammation in healthy horses 
and the concentration of endotoxin in the breathing zone of young 
racehorses is associated with the etiopathogenesis of IAD. Noxious gases 
frequently present in a stable may be involved in causing IAD. Sulfur 
dioxide, nitrogen dioxide, ozone, carbon monoxide, ammonia, hydrogen 
sulphide and methane are the most commonly recognized substances in 
ambient air, however the role of these gases in the development of IAD 
remains unsubstantiated (Christley and Rush 2007).  
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2.4 Diagnosis of LAI in Horses 
 
2.4.1 Collection of History and Clinical Signs 
 
Thorough collection of a complete history is important for the correct 
diagnosis of LAI. Housing and feeding management, recurrence of clinical 
signs, seasonality and response to previous treatment should be 
ascertained (Hotchkiss et al. 2006). Horses with RAO or SPA-RAO have 
indistinguishable clinical signs, however differentiation may be achievable 
by evaluation of the historical information. Prolonged respiratory recovery 
time after exercise and cough during exercise are common in horses with 
RAO, SPA-RAO or IAD (Hotchkiss et al. 2006). Clinical signs of disease 
may worsen by stabling in dusty environments or on pasture in summer 
months depending on the specific disease present (Dixon et al. 1995b). 
Horses with IAD may present with history of coughing and/or exercise 
intolerance, however signs of respiratory insufficiency at rest are absent 
(Robinson 2003). Exclusion of other causes of poor performance, such as 
orthopaedic problems or dynamic upper airway disease, is mandatory 
during the investigation of horses with IAD (Couetil et al. 2001). In horses 
with RAO or SPA-RAO, nasal discharge and intermittent cough may be 
noticed by owners, with/without an increase in respiratory effort. 
Recording the duration of clinical signs of respiratory disease may be 
useful to identify the chronicity of the disease (Hotchkiss et al. 2006). In 
more chronic cases of RAO, prolonged increased expiratory effort induces 
hypertrophy of the abdominal muscles (“heave line”) (Dixon et al. 1995b). 
Fever is not a typical clinical sign of RAO, and weight loss may be present 
in more severe cases as increased respiratory effort can result in 
decreased appetite and increased energy consumption by respiratory 
muscles (Hotchkiss et al. 2006). Some authors found tracheal auscultation 
after a rebreathing bag test to be more successful for the detection of 
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abnormal sounds than thoracic auscultation, due to less attenuation of 
breath sounds at this site (Dixon et al. 1995b). 
 
Recurrent airway obstruction and SPA-RAO typically affect horses older 
than seven years of age, while IAD is more frequent in younger horses. 
However, older horses may also be affected by IAD (Robinson 2001). 
Many breeds may be affected by LAI diseases and there is no sex 
predilection for any LAI disease. Some authors have suggested that 
genetic factors may predispose to RAO but more data are needed to 
elucidate the heritability of this disease (Ramseyer et al. 2007). 
 
2.4.2 Airway Endoscopy, Cytology and Bacteriology  
 
Endoscopic examination of the lower respiratory tract and cytology of 
broncho-alveolar and tracheal lining fluids are objective and useful 
techniques to achieve a diagnosis of LAI in horses (Mair 1996). Endoscopy 
allows the visualization and semi-quantification of respiratory secretions 
present in the trachea. Dynamic collapse of the intrathoracic trachea may 
be visualized during coughing. A positive correlation between the severity 
of the disease and the volume of mucus/mucopus in the trachea is 
present in horses with RAO (Dixon et al. 1995c; Robinson et al. 2003). 
Cytological examination of tracheal aspirate samples allows determination 
of differential counts of inflammatory cells. In addition, tracheal aspirate 
samples can be submitted for quantitative and qualitative bacteriology and 
virology.  
 
Broncho-alveolar lavage (BAL) in general is a safe procedure and is 
suitable for assessment of diffuse pulmonary disorders where a single 
sample obtained from a limited region of the lungs is likely to be 
representative of the entire lungs (McGorum et al. 1993e). Collection of 
broncho-alveolar lining fluid (BALF) for differential counts of inflammatory 
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cells in the distal airways is considered necessary for the diagnosis of 
RAO, SPA-RAO and IAD (Dixon et al. 1995a; Couetil et al. 2007). 
Recurrent airway obstruction and SPA-RAO are characterised by an 
increased neutrophil count in BALF (>25%; normal <5) (Dixon et al. 
1995c). Inflammatory airway disease is characterised by mild neutrophilia, 
lymphocytosis and monocytosis, and occasionally eosinophilia, in BALF 
cytology (Moore et al. 1995; Couetil et al. 2001; Couetil et al. 2007). 
There is insignificant intra-subject variability in BAL cytology in healthy 
horses kept in a dusty environment (Gerber et al. 2004). In addition, 
healthy horses stabled in a dusty environment may have a neutrophil 
count in the BALF of >5% and therefore it is necessary to combine the 
interpretation of BAL cytology with history and other clinical findings 
(Robinson 2001). The presence of increased mucus, exfoliated epithelial 
cells and fungi is highly suggestive of impeded mucociliary clearance or 
respiration of highly dusty air (Kaup et al. 1990b). Recurrent airway 
obstruction is characterised by a high neutrophilia while in IAD 
neutrophilia is less prominent (Robinson 2001). In addition, IAD may be 
associated with eosinophilia and increased count of mast cells (Couetil et 
al. 2007). The value of environmental challenge to discriminate RAO from 
IAD in affected horses has been suggested, since in IAD affected horses 
there is no change in the respiratory pattern after the challenge (Couetil 
et al. 2007).  
 
Tracheal aspirate (TA) cytology is considered less reliable to quantify 
lower airway inflammation as results are not correlated with BALF 
neutrophil counts or lung histology in horses with RAO (Dixon et al. 
1995c). Great variability is present in the neutrophil count in TA obtained 
from healthy individuals (Derksen et al. 1989). However, in Thoroughbred 
racehorses the neutrophil percentage in TA from horses without evidence 
of respiratory disease was <20%, while coughing horses had neutrophil 
percentage >20% (Christley et al. 2001); therefore TA may still be a 
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useful diagnostic tool in certain groups of horses. Furthermore, the 
presence of bacteria in TA in absence of clinical signs consistent with 
bacterial infection is suggestive of colonization secondary to a defective 
mucociliary clearance (Dixon et al. 1995c). 
 
2.4.3 Lung Function Testing 
 
Measurement of lung function may supply data useful to understand the 
severity of airway obstruction, allowing an objective monitoring of the 
patient’s progress. The diagnostic value of lung function testing using 
conventional methods is often limited due to the low sensitivity of the 
methodology: horses with RAO in clinical remission are not significantly 
different from normal horses (Robinson et al. 2000). However, newer 
methodologies, such as forced expiration oscillometry or volumetric 
capnography, have increased the sensitivity compared to conventional 
techniques (Couetil et al. 2000). Because of the requirement of specific 
equipment and expertise these techniques are used mainly in research 
settings (Robinson et al. 2000). 
 
Tests of lung function are aimed at providing a quantitative assessment of 
changes in the elasticity of the lung and of the resistance of the non-
elastic portion of the respiratory tract (Robinson 2003). Dynamic lung 
compliance (Cdyn) and pulmonary resistance (RL) are common pulmonary 
function measurements however they are insensitive to small changes in 
pulmonary function (Marlin and Deaton 2007). Maximal changes in 
transpulmonary or pleural pressure (commonly referred as ΔPplmax) is 
measured directly by placing a catheter in the pleural cavity (Littlejohn 
and Bowles 1980), or indirectly by means of an oesophageal catheter 
connected to a pressure transducer that offers an accurate estimate of 
pleural pressure (Derksen and Robinson 1980). Forced oscillatory 
mechanics appear to be very sensitive to detect changes in lung function 
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and are non-invasive as flow and pressures are measured at the nares 
(Young and Tesarowski 1994). Forced expiration has also been evaluated 
in horses but is invasive and technically demanding therefore impractical 
in routine clinical settings (Couetil et al. 2001). Tidal breathing flow-
volume loops indices are obtained non-invasively from conscious horses 
wearing a facemask and a pneumotachograph (Art and Lekeux 1988) and 
are useful indicator of disease severity in RAO (Herholz et al. 2003a). 
Respiratory inductance plethysmography provides a measurement of lung 
volume by means of recording bands placed around thorax and abdomen 
(Marlin et al. 2002).  
 
Arterial and venous blood gas tensions (PaO2 and PaCO2; arterial partial 
pressures for oxygen and carbon dioxide, respectively) measurement are 
commonly used in clinical practice and are the best indications of the 
overall pulmonary gas exchange (Marlin and Deaton 2007). Hypoxemia is 
a frequent finding in RAO, however hypercapnea is more variable due to 
lower solubility of CO2 compared to oxygen. With successful treatment of 
RAO, PaO2 returns to normal and the blood oxygen content tends to be 
normal. Therefore, arterial blood analysis is useful for monitoring the 
progress of treatment of RAO. However, some horses may be hypoxic 
with no clinical signs (called chronic idiopathic hypoxemia), possibly 
secondary to alveolar hypoventilation, as increased PaCO2 is commonly 
present also (Dixon et al. 1995a). Respiratory acidosis is rare because of 
the limited development of hyperapnea (Robinson 2003; Christley and 
Rush 2007; Couetil et al. 2007). 
 
In horses with clinical signs of RAO, ΔPplmax, RL, peak inspiratory and 
expiratory airflows and work of respiration are increased while ratio of 
inspiratory time to total breath time, PaO2, Cdyn are usually decreased 
(Petsche et al. 1994; Dixon et al. 1995c). A wide range of normal values 
for these parameters has been reported in several studies making 
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interpretation of results from individual test difficult (Petsche et al. 1994; 
Dixon et al. 1995c; Herholz et al. 2003b). It is also possible that location, 
temporal, daily and seasonal variations may contribute to differences 
between results of studies (Robinson 2001). 
 
The prevalence of functional abnormalities in the general population of 
horses with IAD is unknown. However, lung function testing may help to 
differentiate IAD from clinical forms of RAO, potentially associated with a 
more severe lung dysfunction (Christley and Rush 2007). 
 
2.4.4 Diagnostic Imaging Techniques 
 
Radiography is useful in detecting gross abnormalities in the anatomy of 
the respiratory system. However it is an insensitive methodology for the 
detection of RAO; a broncho-interstitial pattern may be present in more 
chronic and severe cases. Some authors described a flattening or 
concavity of the diaphragm subsequent to alveolar over-inflation, and the 
presence of single or multiple distended bronchi is indicative of 
bronchiectasis (Lavoie et al. 2004). 
 
Thoracic ultrasonography has not been found to be useful for the 
diagnosis of LAI, since only the pleural surface can be appreciated and 
pathology predominantly is associated with airways (Reef et al. 1991). 
Some irregularity may be seen on the surface of the visceral pleura 
however the importance of this finding is difficult to interpret, as this 
change is a non-specific finding.  
 
Scintigraphic examination has been used to determine the alveolar 
clearance in horses in research settings but has found limited application 
in clinical protocols (Votion et al. 1999a). This technique was developed to 
monitor the ratio of inhalation and perfusion in the lower airways of 
 44
horses and a mismatch of inhalation and perfusion was present in horses 
with RAO. This methodology was found to be more sensitive than lung 
function testing in detecting early changes in lower airways induced by 
RAO (Votion et al. 1999b). 
 
2.4.5 Haematology and Serum Biochemistry 
 
Haemograms, leukograms and fibrinogen are usually within normal limits 
in horses with RAO, SPA-RAO or IAD. A mild and inconsistent increase in 
packed cell volume is a possible finding as the result of an elevated mean 
erythrocyte corpuscular volume.  
 
2.4.6 Environmental Challenges and Managements 
 
The clinical response to treatment or the response to an environmental 
challenge has been shown to be a reliable diagnostic tool to identify 
horses with RAO (McGorum et al. 1993d). A positive response is 
consistent with the onset of clinical signs subsequent to exposure to dusty 
and mouldy hay or dusts (McPherson et al. 1979; McGorum et al. 1993b, 
c; Gerber et al. 2000; Gerber et al. 2004).  
 
The importance of challenge responses implies a relationship between 
environmental management and control of disease. It is recognised that 
reducing the exposure to respirable factors triggering the hypersensitivity-
response is the main goal in treating and preventing LAI in horses 
(McGorum et al. 1993d). Reducing exposure to feed-associated dusts, 
moulds and endotoxins is achieved by soaking hay for adequate periods of 
time (30-45 minutes) before feeding and gradually introducing a pellet or 
haylage diet (Ramseyer et al. 2007). The type of bedding chosen also 
influences the quantity of antigens present in the stable environment. 
Bedding made of wood shavings, cardboard, paper or rubber mats is the 
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best option since they produce minimal amounts of dusts and moulds, 
while straw is known to dramatically increase the presence of respirable 
particles in the air (Woods et al. 1993). Using low dust bedding materials 
have been shown to decrease the respirable dust burden by 97% and to 
decrease aeroallergen challenge (Woods et al. 1993). Ideally, ventilation 
should be improved, to enhance the removal of airborne particles. If 
possible, daily access to pasture would be expected to improve airway 
health of affected horses. Ideally, introducing grazing as the sole source 
of nutrition by keeping animals on pasture 24h a day is the preferred 
management for horses with RAO, as exposure to the antigens and 
endotoxins involved in the etiopathogenesis of the disease is likely to be 
minimal (Robinson 2001). Stabling horses with SPA-RAO is mandatory, 
since the factors triggering the clinical signs are present in the pasture, 
however the stabling management should ensure a low dust environment 
(Robinson 2001; Christley and Rush 2007; Couetil et al. 2007). 
 
2.4.7 Immunological Testing 
 
Intradermal allergen testing is useful in human medicine and other 
domestic animals (Li 2002). Due to high false positive responses 
documented in numerous studies, these tests have minimal application in 
horses with LAI (McGorum et al. 1993a; Jose-Cunilleras et al. 2001; Lorch 
et al. 2001; Wong et al. 2005). 
 
2.4.6 Exhaled Breath Condensate Analysis in Horses 
 
Exhaled breath condensate analysis is a recent addition to respiratory 
medicine in humans and has been the subject of considerable 
investigation and application (Horvath et al. 2005). The non-invasive 
nature of sample collection is an advantage of this methodology over 
conventional methods of diagnostic investigation (eg. collection of TA, 
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BAL). In veterinary medicine, EBC analysis has been assessed in rodents, 
rabbits, elephants, swine, calves, dogs, cats and horses (Reinhold et al. 
2000; Wyse et al. 2004; Wyse et al. 2005; Zollinger et al. 2006). 
 
Exhaled breath condensate has undergone only limited investigation in 
horses and H2O2 has been the component of EBC studied most frequently. 
Deaton et al. (2004) found a relationship between H2O2 in the EBC, the 
antioxidant status of the airways (ascorbic acid concentration) and TA and 
BALF cytological findings in horses with RAO and healthy controls. 
Hydrogen peroxide was used as an indicator of the oxidative status of the 
airways and an inverse correlation between concentrations of ascorbic 
acid and H2O2 was found (Deaton et al. 2004a). In addition, a significant 
relationship was found between the concentration of H2O2 in EBC and 
neutrophil count in BALF, suggestive of a relationship between airway 
inflammation and EBC H2O2 content (Deaton et al. 2004b). A further study 
by this research group did not find a correlation between EBC H2O2 
concentration and the degree of airway inflammation in a study of 
environmental challenge in horses with RAO (Deaton et al. 2005a). A 
possible explanation of the lack of association is the antigen exposure may 
not have been severe enough to cause oxidative stress and an increase in 
H2O2 production (Deaton et al. 2005a). Environmental challenge may have 
been sufficient to cause the neutrophilic inflammation but insufficient to 
cause oxidative stress and increased H2O2 production. In that study some 
variation in EBC H2O2 concentration was present for repeated 
measurements over a period of 24 hours (Deaton et al. 2005a). 
Considerable variation in EBC H2O2 concentration has been described in 
studies of human patients (van Beurden et al. 2002a) and it is possible 
that a similar degree of variation may occur in horses. Determining the 
magnitude of any variation in EBC H2O2 concentration is necessary to 
objectively define the usefulness of H2O2 as a marker of LAI. 
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A study performed by Wyse et al. (2005) involved stabling a group of 
horses in two different management systems (high vs low dust). A 
tendency of EBC H2O2 concentration to increase in the high dust 
management was found, however the difference between groups was not 
statistically significant (Wyse et al. 2005). In that study another substance 
indicative of oxidative stress, ethane, was studied. Ethane concentration 
was increased significantly after the environmental challenge suggesting 
that environmental challenge was appropriate to cause oxidative stress in 
the airways. It is possible that H2O2 is a less sensitive biomarker of airway 
oxidative stress and inflammation, requiring greater antigen stimulation 
than ethane for increased production in the airways. However other 
factors may be involved in the regulation of H2O2 production in EBC in 
horses. Further studies are required to assess the usefulness of EBC H2O2 
for the detection and monitoring of LAI in horses. Furthermore, flow 
dependency of H2O2 production is recognised in humans, however the 
extent of variability induced by expiratory flows is unknown in horses.  
 
The pH of EBC collected from horses has not been reported previously. In 
human medicine, pH is considered a robust indicator of LAI (Vaughan et 
al. 2003) despite some methodological issues related to its measurement 
(Kullmann et al. 2007). Given the ease of collection and measurement, 
EBC pH could be a useful indicator of LAI in horses if it had similar 
characteristics of repeatability/reproducibility, to that of human EBC and a 
similar relationship to the presence and severity of disease in the lower 
airways.  
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Aims of the Study 
 
The studies contained in this thesis had three aims: 
1- Develop a portable and non-invasive device to collect EBC from 
standing horses. A non-portable device has been described 
previously (Deaton et al. 2004b). A portable device for EBC 
collection from horses was described by Wyse et al. (2005) and the 
device used in this study is a further evolution of that equipment; 
2- Assess intra-day and inter-day variations in EBC H2O2 concentration 
and pH;  
3- Determine the effect of lower airway health on EBC H2O2 
concentration and pH. Specifically, EBC H2O2 concentration and pH 
in healthy horses on pasture, healthy horses housed in stables and 
horses with LAI were compared. 
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CHAPTER 3 – MATERIALS AND METHODS FOR COLLECTION AND 
ANALYSIS OF EBC FROM HORSES 
 
3.1 Collection of EBC 
 
Equipment for collection of exhaled condensate (EBC) was developed and 
constructed for the purposes of the study. 
 
3.1.1 Construction of the Face Mask 
 
Exhaled breath condensate was collected from horses by use of a face 
mask that was connected to a condensation chamber by flexible 
impermeable plastic tubing (Figure 3.1; see Appendix 3 - Figure 6). The 
mask was obtained by modifying a plastic horse muzzle. Fibreglass was 
used to occlude all but two holes of the muzzle; each of the remaining 
two openings of the muzzle were modified to allow the attachment a one-
way valve (Salford non-rebreathing valve 35 mm diameter, Cranlea & 
Company, Birmingham, UK) (see Appendix 3 - Figure 1, Figure 2 and 
Figure 5). A rubber ring was placed between the valve and the hole in the 
mask to achieve an airtight connection (see Appendix 3 - Figure 3). An 
elastic rubber shroud placed on the rim of the mask provided a seal on 
the face of the horse (see Appendix 3 - Figure 4). Achievement of an 
airtight seal when the mask is in place on the muzzle of the horse is 
essential to obtain the negative pressure in the system necessary to 
activate the valves, ensuring one-way flow of air through the collection 
device during respiration (Figure 3.2). In addition, an airtight seal avoids 
contamination of the EBC sample with ambient air. Each valve had an 
internal diameter of 35mm and initial testing (data not shown) revealed 
respiration through the device by the horses did not induce any changes 
in the respiratory pattern (considered as respiratory effort and respiratory 
rate).  
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Figure 3.1: Photograph of equipment used to collect exhaled breath 
condensate from a mature horse. The airtight face mask (A) is attached to 
flexible rubber tubing (B) that is connected to the condensation chamber 
immersed in an ethanol/liquid nitrogen slurry (C). The system includes two 
one-way non-rebreathing valves incorporated into the face mask (D) and a 
one-way valve at the outlet of the condensation chamber (E) to prevent 
contamination of the sample with environmental air. 
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Two valves were used to decrease the resistance of the device to airflow, 
limiting any change in inspiratory or expiratory flow rates. Avoidance of 
changes in air flow rates was considered important to prevent any distress 
to the horse during the procedure. 
 
3.1.2 Condensation Chamber 
 
The one way valves of the mask were connected with flexible 
rubber/plastic tubes (Cranlea & Company, Birmingham, UK) to the 
condensation chamber (see appendix Figure 7A). The condensation 
chamber was comprised of two main parts: an inner polypropylene (PP) 
beaker in an outer plastic container filled with an ethanol/liquid nitrogen 
slurry (see Appendix 3 - Figure 7B). The outer chamber containing the 
slurry was placed in a polystyrene box to improve thermal insulation. The 
internal shape of the chamber was designed to direct the flow of expired 
breath towards the bottom of the PP container, similar to that described 
by Wyse et al. (2005). Exhaled breath exited the chamber by flowing up 
along the outer walls of the condensation chamber and out of the system 
through a one-way valve (see Appendix 3 - Figure 7A). The rationale to 
place a third valve in this location was to prevent diffusion of 
environmental air into the chamber and contamination of the sample. The 
smaller inner diameter of the condensation chamber was 35mm.  
 
The temperature of the ethanol/liquid nitrogen slurry was monitored with 
a thermometer with a lower detection limit of -80˚C to ensure the 
temperature was ≤-80˚C throughout collection of EBC. Furthermore, the 
freezing point of ethanol is -114.1˚C and some solid ethanol was always 
observed in the slurry indicating that the temperature of the slurry was 
very close to that value and indeed ≤-80˚C. Before collection of each EBC 
sample, liquid nitrogen was added to the slurry to ensure that similar 
temperatures were reached for each collection. After the last addition of 
 52
liquid nitrogen the temperature was found to remain below -80˚C for at 
least 2 hours (data not shown). Measuring the temperature inside the 
condensation chamber was not attempted. The temperature on the 
internal surface of the PP container, where the condensation of breath 
occurred was considered to be that of the liquid nitrogen/ethanol slurry.  
 
MUZZLE
ONE-WAY
VALVE
LIQUID 
NITROGEN 
ETHANOL 
SLUSH
ONE-WAY
VALVE
EBC
CONDENSATION 
CHAMBER
Figure 3.2: Schematic representation of the system used to collect exhaled 
breath condensate from horses. Exhaled breath is conveyed to the 
condensation chamber (magnified version on the right) by means of the one-
way valve and rubber tubing. The internal shape of the chamber was designed 
to direct the flow of expired breath towards the bottom of the PP container 
 
3.1.3 Cleaning The Equipment 
 
The masks, valves, connection tubes and PP condensation chambers were 
cleaned after collection of EBC from each horse. Each part was 
disconnected and soaked in diluted combination of polymeric biguanyde 
hydrochloride, alkyldymethyl benzyl ammonium chloride and didecyl 
dymethil ammonium chloride as directed by the manufacturer (Trigene 
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Advance, Medichem, Kent, UK). After soaking for a period of at least 20 
minutes, each piece was rinsed thoroughly with hot tap water and dried at 
room temperature. This disinfectant was chosen for its broad bactericidal, 
viricidal, fungicidal and sporicidal properties, including activity against 
common infectious agents of horses. In addition, the disinfectant solution 
was compatible with plastics and fibreglass used in the construction of the 
equipment. The pH of the prepared disinfectant solution is 5.5. The pH 
measured in a PP container (inner condensation chamber) filled with 
1.5ml of tap water was identical before and after disinfection (data not 
shown) confirming that no disinfectant remained after rinsing of the 
equipment. 
 
3.1.4 Animals 
 
The signalment and clinical data of the horses used in the studies 
described in this thesis are provided in the respective chapters describing 
the individual studies (chapters 3 and 4). Each sample was obtained from 
standing, non-sedated horses and was achieved in the stall where the 
horse was housed. This method allowed collection at the owner’s 
premises, without the need to move the horse to the hospital. In addition, 
some EBC samples were collected from hospitalised patients at the 
Weipers Centre Equine Hospital Faculty of Veterinary Medicine, University 
of Glasgow. This possibly decreased the effects of travelling, which could 
have a potential role in inducing airway inflammation (Ito et al. 2001) and 
influence the results of EBC analysis. However, some horses were 
collected from immediately after arrival at the hospital, as they had been 
admitted as an emergency due to exacerbation of RAO or as outpatients 
presented for reassessment of RAO. 
 
On average, 1.4 ml of EBC was collected in 15 minutes in a frozen solid 
form (range 0.5 to 7 ml) from each horse. Each sample of EBC obtained 
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was frozen in a polystyrene container filled with ice and was thawed at 
room temperature immediately prior to analysis. 
 
3.2 Measurement of EBC H2O2 Concentration and pH 
 
3.2.1 Measurement of EBC H2O2 Concentration 
 
3.2.1.1 Spectrophotometric assay 
 
Each EBC sample underwent analysis within 1 hour of collection. The 
concentration of H2O2 was determined with a spectrophotometric assay as 
described by Gallati and Pracht (1985). A solution of horseradish 
peroxidase was prepared by diluting 44.2mg of powder (see appendix 4 - 
Figure 1A) in 66ml of distilled water (75IU/L). A solution of 3,3’,5,5’-
tretramethylbenzidine (TMB) was prepared diluting 1mg of TMB (see 
appendix 4 - Figure 1B) in 0.5ml of acetone, 0.5ml methanol and 9ml of 
0.42M citrate buffer (pH 3.84). Fifteen µl of horseradish peroxidase 
solution, 140µl of TMB and 140µl of EBC were mixed in quadruplets at 
room temperature in a darkened room and the reaction stopped after 10 
minutes by adding 20µl of 9M sulphuric acid (see Appendix 4 - Figure 2A). 
The product of this reaction was then immediately analysed with an 
automated microplate reader (FLUOstar OPTIMA, BMG labtech, UK) at the 
wavelength for absorbance of 450nm (see Appendix 4 - Figure 2B) (Gallati 
and Pracht 1985).  
The concentration of H2O2 was calculated from a standard curve of known 
concentrations of H2O2 prepared for each assay. Linearity of the standard 
curve was acceptable (r2>99%) for the range 0 to 10µM. 
 
 
 
 
 55
3.2.1.2 Lower detection limit and limit of quantification 
 
The lower detection limit (LDL) was obtained by first drawing a standard 
curve of H2O2 concentration and then calculating the concentration of a 6 
series of quadruplicates of blank samples. The LDL was calculated as the 
mean value of all the blank samples plus three times the standard 
deviation. The limit of quantification (LOQ) was calculated as three times 
greater than the LDL. The calculated LDL was 0.1µM and the LOQ was 
0.3µM. 
 
3.2.2 Measurement of EBC pH 
 
3.2.2.1 Introduction 
 
As described previously in studies of pH in EBC from human patients 
(Kullmann et al. 2007), several technical issues related to measurement of 
equine EBC pH need to be addressed and resolved to improve the 
understanding of this parameter for the assessment of LAI. A principal 
issue is the time necessary to obtain a stable reading from an EBC 
sample. Once the probe of a pH meter is placed in a sample of EBC, up to 
20 minutes may be necessary to obtain a stable reading of pH. In human 
studies the reason for the instability of EBC pH may be explained by the 
presence of volatile compounds in EBC and time required for these 
compounds to reach stability. The mechanisms of this process is not 
understood entirely (Kullmann et al. 2007). To achieve a more 
reproducible measurement of pH a common procedure is to bubble a 
noble gas such as argon through the sample of EBC to facilitate the 
evaporation of volatile substances (Borrill et al. 2006; Kullmann et al. 
2007). Other authors have tried to standardise EBC pH readings by 
addition of CO2 to the sample (Kullmann et al. 2007).  
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The aim of the present study was to evaluate the effect of deaeration with 
argon and CO2 on the measured pH of EBC collected from horses. Three 
methodologies (measurement of plain EBC, after deaeration with argon or 
deaeration with CO2) to measure pH of EBC collected from horses were 
evaluated to determine which provides the most reproducible and time 
effective measurement. 
 
3.2.2.2 Materials and methods 
 
Animals: Four horses (4 mares; 2 Thoroughbred Cross, 1 Warmblood 
cross, 1 Pony; age 16±4 years) were used for this study. Horses were 
stabled on paper bedding, fed soaked hay and the stable window was 
maintained in an open position to facilitate ventilation. One horse was 
healthy and the remaining three horses had a history of more than one 
episodes of LAI in the past (RAO, n=1; IAD n=2); however no horse had 
clinical signs of LAI at the time of the study. One sample of EBC was 
obtained from each horse. Sample collection was performed over a period 
of 15 minutes while the horse was in the stable. The respiratory rate and 
pattern of the horse were monitored during sample collection. Samples 
were kept frozen and thawed immediately prior to the time of pH 
measurement. 
 
pH measurement: measurements of pH in EBC were obtained using a 
bench pHmeter (pH21, Hanna Instruments ltd) with an accuracy of 
±0.02pH (see Appendix 4 - Figure 3A). A 6mm diameter (see Appendix 4 - 
Figure 3B), glass body pH-electrode was used to measure the smallest 
volume samples obtained (at least 0.3ml) (HI-2031B, Hanna Instruments 
ltd., UK). The pH meter was calibrated using standard solutions as 
recommended by the manufacturer before each set of measurements. 
The measurement of pH was obtained by immersion of the electrode in 
the sample of EBC and allowing the reading to stabilise (up to 15 min). In 
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the current study, a measurement of the pH was considered stable when 
the displayed value was unchanged for a minimum of 3 minutes.  
Each sample of EBC collected was divided in 3 aliquots and each pair was 
assigned to one of the following groups: 
1. PLAIN group: the pH was measured in the aliquot of EBC that had 
not been pre-treated. The numerical value provided by the pH 
meter was recorded approximately every two minutes (1,3,5,7 and 
10 min) and one final reading after the pH of the sample was 
stable (did not change within 3 minutes). 
2. ARGON group: the pH was measured prior to bubbling Argon gas 
through the sample. The pH was then measured while argon was 
bubbled through the sample and the measured value recorded 
approximately every two minutes (1,3,5,7 and 10 min). After 10 
minutes the bubbling of Argon was discontinued and pH recorded 
approximately every two minutes for 10 minutes and one final 
reading once the measured pH was stable (unchanged for 3 
minutes). 
3. CO2 group: the pH was measured prior to bubbling CO2 through the 
sample. The pH was then measured while CO2 was bubbled 
through the sample and the value was recorded approximately 
every two minutes (1,3,5,7 and 10 min). After ten minutes the 
bubbling with CO2 was discontinued and the value of pH recorded 
approximately every two minutes for 10 minutes and one final 
reading once the measured pH was stable (unchanged for 3 
minutes).  
 
Statistical analysis: mean, standard deviation (SD) and coefficients of 
variation (CV) were calculated for these measurements. 
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3.2.2.3 Results 
 
A mean EBC volume of 3.5±1.1ml was obtained during the 15 minute 
collection period. All the horses tolerated the collection procedure and the 
respiratory rate (10±2 breaths/minute) and respiratory pattern were 
unaltered during the procedure. The pH measurements obtained for each 
group are provided in Table 3.1. The mean standard deviation and 
coefficient of variation for each group are presented in Table 3.2. The pH 
of EBC samples over time without deaeration, argon deaeration or CO2 
standardization is demonstrated in Figure 3.3. 
 
 
Table 3.1 : Values of pH in plain aliquots of EBC, aliquots of EBC deaerated 
with Argon and CO2 in four horses. 
 
    PLAIN ARGON CO2
     
10min 
deaeration
10 min after 
deaeration 
10 min 
deaeration 
10 min after 
deaeration 
mean 5.15 5.325 5.16 4.25 4.065 
SD 0.014 0.007 0.042 0.085 0.007 Horse 1 
CV 0.003 0.001 0.008 0.02 0.002 
       
mean 5.11 5.29 5.08 4.14 4.065 
SD 0.042 0.014 0.057 0.057 0.021 Horse 2 
CV 0.008 0.003 0.011 0.014 0.005 
       
mean 5.76 6.84 6.06 4.23 4.08 
SD 0.014 0.071 0.014 0.014 0.057 Horse 3 
CV 0.002 0.01 0.002 0.003 0.014 
       
mean 5.505 7.215 6.285 4.205 4.07 
SD 0.092 0.064 0.092 0.007 0.014 Horse 4 
CV 0.017 0.009 0.015 0.002 0.003 
 
 
 
 
Table 3.2: Mean, standard deviation (SD) and coefficient of variation (CV) 
values for measurement of pH in plain aliquots of EBC and aliquots of EBC 
deaerated with argon or CO2 
 
  Mean SD CV 
plain 5.38 0.309 0.057 
Argon 5.65 0.615 0.109 
CO2 4.07 0.007 0.002 
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  Figure 3.3: pH of exhaled breath condensate over time in plain samples, after 
Argon deaeration and CO2 standardisation. The pH was measured at each time 
point (1,3,5,7 and 10 minutes) during deaeration and when the pH stabilised 
(“final”) after discontinuation of treatment with Argon or CO2. For the plain 
EBC samples, pH was measured every 2-3 minutes after until a stable reading 
was obtained. 
 
  
 
3.2.2.4 Discussion 
 
This study suggests that measurement of pH in a plain sample of EBC is 
more repeatable over time than that of samples that have undergone 
deaeration with either argon or CO2 gas. In human studies measurement 
of EBC pH in plain samples is time-consuming and poorly repeatable and 
deaeration of the samples with argon has been shown to improve 
measurement repeatability (Hunt et al. 2000; Vaughan et al. 2003; Borrill 
et al. 2005). Deaeration of EBC samples by argon deaeration is commonly 
performed to remove CO2 as this is an unwelcome “noise” (Vaughan et al. 
2003; Borrill et al. 2005). It was found in studies of human patients that 
deaeration with argon may have very little effect on samples with pH <6 
(Gessner et al. 2003; Vaughan et al. 2003). Gessner et al. (2003) 
suggested that at pH<6 either CO2 is not efficiently removed or the pH is 
mainly determined by other acids (Gessner et al. 2003). However, acidic 
EBC pH could be caused by airway acidification at any level of the 
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respiratory tract and the source and nature of EBC acidification remain 
controversial (Effros et al. 2006; Hunt 2006). In the current study the 
effect of Argon deaeration on the pH of EBC collected from horses was 
unpredictable. The pH increased one pH unit during deaeration, however 
pH decreased rapidly after discontinuation of deaeration in samples from 
two animals, while in the samples from two other horses, bubbling argon 
through the sample had no effect on the pH. Furthermore, after 
discontinuation of deaeration with argon, the pH of the EBC samples 
tended to decrease. The reason for the different response to deaeration 
with argon between samples collected from human and equine patients is 
unknown. This may reflect a difference in the components of EBC 
between the two species, but also in the collection methodologies. Further 
studies would be required to identify and quantify other components of 
equine EBC. The importance of CO2 on pH of EBC collected from humans 
has been widely discussed (Gessner et al. 2003; Vaughan et al. 2003; 
Borrill et al. 2005; Horvath et al. 2005; Borrill et al. 2006; Horvath et al. 
2006; Kullmann et al. 2007). The role of other substances, such as 
ammonia, in the de-aeration-induced changes in EBC pH are not 
understood (Wells et al. 2005; Effros et al. 2006). However, some authors 
found that ammonia concentration in EBC was not affected by deaeration 
(Kullmann et al. 2007). It is possible that ammonia content in EBC 
collected from horses is high enough to affect the pH (Whittaker A., 
personal communication). 
 
In a study on human patients, standardization of  CO2 partial pressure in 
EBC improved the reproducibility of pH measurement by six times 
compared to argon deaeration (Kullmann et al. 2007). The authors found 
that systematically measuring the partial pressure of CO2 in the EBC and 
correcting the pH obtained by calculating the negative logarithmic 
correlation between pH and partial pressure of CO2 of EBC considerably 
improved the reproducibility of EBC pH measurement (Kullmann et al. 
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2007). Since this methodology keeps in account the amount of CO2 
present in EBC and adding CO2 to the sample stabilises partial pressure of 
CO2 in EBC and is more reproducible measure of EBC pH; it should be 
considered a more reliable method to measure EBC pH than argon 
deareation (Kullmann et al. 2007). In the current study measurement of 
partial pressure of CO2 in EBC samples collected from horses was 
attempted unsuccessfully in a preliminary study using a portable bloodgas 
analyser (data not shown). It is possible that the use of a more sensitive 
blood-gas analyser may give results comparable to the study of Kullmann 
et al. (2007) and justify the use of this methodology in the horse, but this 
equipment is very expensive and was not available for this study. In the 
current study, bubbling CO2 through EBC samples induced a rapid 
decrease in pH that tended to remain low after CO2 bubbling was 
discontinued. The low coefficient of variation between the samples from 
different animals (CV=0.02) indicates that bubbling CO2 induced a 
dramatic change in the pH that is independent of the initial EBC pH as the 
procedure saturates the sample of EBC with CO2, which in solution is in 
equilibrium with carbonic acid (and H+ ions).  
 
To the author’s knowledge there is one report in the literature of 
measurement of EBC pH from calves (Zollinger et al. 2006; Knobloch et al. 
2008). Zollinger et al. (2006) found that the pH was slightly acidic in these 
species compared to humans, ranging from 5.43 to 6.46 (mean5.74 ± 
0.21) in non-degassed EBC samples. Comparing these results with those 
from other species may give more information to explain the different 
response to deaeration between human and equine EBC. The results of 
this study show that pH measurement is most reproducible on the plain 
sample compared the argon and CO2 standardisations. 
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3.3 Repeatability of the Methodology for Collection and Analysis 
of EBC H2O2 Concentration and pH 
 
3.3.1 Introduction 
 
The method for collection and analysis of EBC H2O2 concentration and pH 
to determine repeatability and magnitude of any experimental errors has 
never been assessed in the horse. Many factors contribute to variability of 
EBC H2O2 concentration and pH measurements reported in studies from 
human patients (Olin et al. 2006). Studies in human medicine have 
assessed variability of EBC H2O2 concentration (Nowak et al. 2001; van 
Beurden et al. 2002a) and pH (Vaughan et al. 2003; Borrill et al. 2005; 
Bloemen et al. 2006) using methods of collection and analysis widely 
validated (Vaughan et al. 2003; Goldoni et al. 2005; Soyer et al. 2006). 
Among the factors that contribute to the variability of the methodology is 
that H2O2 is a very reactive molecule that can undergo rapid degradation 
during interaction with different materials (Horvath et al. 2005). Samples 
of EBC must be analysed immediately or frozen and stored at 
temperatures ≤-70˚C until analysis of  H2O2 concentration (Horvath et al. 
2005). The laboratory method used for determination of H2O2 
concentration in EBC can influence the results as the physiological 
concentrations of EBC H2O2 in human patients are often very close to or 
even less than, the lower detection limit of many of these assays (about 
0.1 µm/L) (Gallati and Pracht 1985; van Beurden et al. 2002b; Svensson 
et al. 2004). The length of EBC collection time has been studied as a 
possible cause for variability in H2O2 concentration, however no significant 
difference in EBC H2O2 concentration was found when samples obtained 
over a collection period of 4 or 10 minutes from human patients were 
compared (Svensson et al. 2004). To date none of the published equine 
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studies (Deaton et al. 2004b; Wyse et al. 2005) assessed intra-day and 
inter-day variations, or whether the length of collection time can have an 
effect on H2O2 concentration. Different methods of sample collection, 
sample storage and analysis could contribute substantially to variations in 
measured values of parameters of interest. Therefore, it is important to 
quantify the variability in specific parameters with methods of collection 
and analysis to allow a more objective interpretation of any study using 
the methodology, to understand to what extent the variability between 
repeated measurements is reflective of a true physiological variation and 
of experimental errors. 
 
The aim of this study is to evaluate the repeatability of methods of 
collection and analysis of EBC using the methodology described in 
paragraphs 3.1 and 3.2 in a group of horses.  
 
3.3.2 Materials and Methods 
 
Exhaled breath condensate was collected from 4 horses (4 mares; 2 
Thoroughbred Cross, 1 Warmblood cross, 1 Pony; age 16±4 years). One 
horse was healthy and the remaining three horses had a history of RAO 
(n=1) or IAD (n=2). No horse had clinical signs of LAI at the time of the 
study. Horses were stabled on paper bedding and fed soaked hay and the 
stable’s window was maintained in an open position to increase stable 
ventilation. 
 
Samples of EBC were collected from horses in the stable at different times 
of the day (4 samples in the morning and 2 samples in the afternoon). 
Exhaled breath condensate was obtained from two horses on two 
separate occasions and from two horses once. At each sample collection 
time point two samples of EBC were collected with an intervening period 
of 5 minutes. Each sample was analysed for determination of H2O2 and pH 
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measurement as described in paragraphs 3.1 and 3.2. Collection time was 
10 minutes for each sample and the samples were stored in ice and 
analysed within one hour from collection. Hydrogen peroxide was 
determined using the spectrophotometric assay described by Gallati and 
Pracht (1985). The pH was measured from plain samples using a bench 
pH meter. 
 
The coefficient of variation was calculated for each pair of H2O2 and pH 
measurements from each horse. 
 
3.3.3 Results  
 
Six paired measurements were obtained resulting in a total of 12 samples 
of EBC. The results for each horse are summarised in Table 3.3.  
All the horses tolerated the collection procedure. The mean respiratory 
rate during collection of EBC was 10±1 breaths per minute and the mean 
volume of EBC retrieved was 1.1±0.7ml per sample. The calculated mean 
coefficients of variation for each paired measurement were 0.05 and 0.01 
for H2O2 and pH, respectively. For the sample collected in the morning in 
horse 2 not enough EBC was collected in 5 minutes and H2O2 
concentration was measured only. 
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 Table 3.3: Results of the study of the repeatability of the collection and 
analysis methodology for EBC H2O2 and pH. Exhaled breath condensate pH, 
H2O2 concentration, respiratory rate and volume collected for each sample and 
the coefficients of variation for pH and H2O2 repeated measurements are 
reported. For horse 2 am not enough sample was available and H2O2 
concentration was measured only.  
 
EBC Round pH H2O2 (μM) 
Resp Rate 
(Bpm) 
Volume 
(ml/10min)  
H2O2 
(μM) pH 
1 5.67 3.48 12 2.5 AVG 3.6 5.74 
2 5.8 3.72 12 2.5 SD 0.17 0.09 
Horse 1 
Am 
     CV 0.05 0.02 
         
1 - 5.67 12 0.6 AVG 5.46 - 
2 - 5.24 10 0.5 SD 0.3 - Horse 2 Am 
     CV 0.06 - 
         
1 6.01 6.7 10 0.8 AVG 6.76 5.99 
2 5.97 6.81 11 0.9 SD 0.08 0.03 Horse 1 Am 
     CV 0.01 0 
         
1 5.81 3.08 8 0.8 AVG 3.2 5.77 
2 5.72 3.31 9 0.7 SD 0.16 0.06 Horse 2 Am 
     CV 0.05 0.01 
         
1 5.43 1.99 10 1.2 AVG 2.09 5.48 
2 5.52 2.18 11 1.1 SD 0.13 0.06 Horse 3 Pm 
     CV 0.06 0.01 
         
1 5.25 0.74 9 0.7 AVG 0.71 5.28 
2 5.31 0.67 9 0.8 SD 0.05 0.04 Horse 4 Pm 
     CV 0.07 0.01 
   AVG 10.3 1.09 Tot CV 0.05 0.01 
   SD 1.36 0.69    
 
3.3.4 Discussion 
 
None of the previously published studies of EBC H2O2 in horses focused on 
the assessment of the methodology of collection and analysis to achieve 
an estimation of the experimental error (Deaton et al. 2004b; Wyse et al. 
2005). No data are published on the assessment of the repeatability of the 
measurements reported in these studies and this may influence the 
reliability of the results reported. In the study by Deaton et al. (2004a) 
there was a significant difference in EBC H2O2 concentration during acute 
and remission phase in horses with RAO. Since data on the repeatability of 
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the collection and analysis methods are not reported in that study it is 
unknown to what extent the methodological error influenced these results.  
However the detection of a highly significant statistical difference in EBC 
H2O2 concentration between acute RAO and RAO in remission, suggests 
that the methodology used in that study is reliable. In the study by Wyse 
et al. (2005) there was no significant difference in EBC H2O2 concentration 
in horses with RAO before and after environmental challenge. Several 
limitations, such as small number of horses and failure to induce 
remarkable LAI,  were discussed by the authors, but no comment was 
made on the methodology of collection (Wyse et al. 2005). The 
repeatability of collection and analysis methods has been widely evaluated 
in studies on EBC H2O2 concentration and pH from human patients 
(Nowak et al. 2001; van Beurden et al. 2002a; Vaughan et al. 2003; Borrill 
et al. 2005; Bloemen et al. 2006). The recommendation in human 
medicine is to report data on the assessment of methodology in a study 
unless the methodology used is validated elsewhere (Horvath et al. 2005). 
The results of this study indicate that measurement of the pH in EBC 
samples is more repeatable (CV: 0.01) than that of H2O2 concentration 
(CV: 0.05). These findings indicate that while some variation in values of 
H2O2 concentration and to a lesser degree EBC pH may be obtained when 
collecting and analysing EBC using the described methodology, the 
variation is very small. Knowing the magnitude of the variation of the 
specific methodology used is important as it allows a more objective 
interpretation of the data obtained. Variability of H2O2 concentration and 
pH in EBC may result from cumulative differences in the steps of the 
analytical process. Slight differences in temperature of the condensation 
chamber, respiratory rate, length of sample collection, time between 
collection and analysis (the first sample collected waits longer to be 
analysed) in room temperature and relative humidity are all possible 
contributors. Even though each factor may contribute minimally to the 
variability, influences may become appreciable in a cumulative manner. 
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Differences in temperature of the collection chamber have been reported 
to influence the concentration of H2O2 in studies from human patients 
(Goldoni et al. 2005). In addition respiratory flow rates have been shown 
to influence EBC H2O2 concentration in studies from human patients 
(Schleiss et al. 2000). Previous studies reported collection of EBC at tidal 
breathing in non-sedated horses but the exact flow rates were not 
reported (Deaton et al. 2004b; Wyse et al. 2005). In the present study, 
EBC collection was also performed at tidal breathing, however the flow 
rates were not measured and it is therefore unknown to what extent this 
may have biased the results. Measurement of flow rates in the standing 
non-sedated horse requires equipment that was not available for this 
study. All horses were accustomed to and tolerated the collection 
procedure therefore it was assumed that there was no change in flow 
rates thorough out the study. Insufficient EBC sample volume was 
retrieved for both analysis of H2O2 and pH measurement and 
measurement of H2O2 concentration was performed only. Collection time, 
time to analysis and storage temperature of the samples significantly 
affect EBC H2O2 concentration (Olin et al. 2006).  Sampling for longer than 
15 minutes and storing samples at -20°C, or leaving the melted sample 
unattended for longer than 1 hour can cause a significant decrease in 
H2O2 concentration (Horvath et al. 2005; Olin et al. 2006). To comply with 
the recommendations of ATS/ERS Task Force on Exhaled Breath 
Condensate, in the current study collection time was 10 minutes and 
analysis was performed within one hour from collection with the sample 
stored frozen at <-80°Cand melted only at the time of analysis. 
 
Measurement of pH of EBC after argon deaeration has been shown to 
have excellent repeatability in humans (Vaughan et al. 2003). No studies 
have been reported on the repeatability of pH measurement of EBC in 
horses. The findings of the current study indicate that quantification of 
EBC pH is highly repeatable. 
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 This study had some limitations. A small number of horses were available 
for the study and two horses were sampled twice to increase the number 
of data available. The type of horse used was also heterogeneous and it is 
unknown if using horses of many different breeds may significantly affect 
the results. The samples of EBC collected were stored frozen in ice and 
analysed within one hour from collection. Some difference between the 
measurements for each pair of samples obtained could have been due to 
the difference in time between collection of the samples (~15 minutes). 
However these limitations were unavoidable with the design of the current 
study and are unlikely to have significantly biased the results. Whether 
using a device to collect two samples at once would have reduced the CV 
is unknown. In one pony insufficient volume of EBC was collected to 
perform both H2O2 concentration and pH measurements. It is possible the 
smaller volume collected may have been a reflection of a smaller tidal 
volume in this breed. Using similar but smaller equipment may maximize 
collection of EBC from smaller breeds.  
 
The CV obtained for repeated collection and analysis of EBC H2O2 
concentration and pH were considered acceptable for the application of 
the methodology for future studies of healthy horses and horses with 
lower airway disease. 
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CHAPTER 4 – STUDY OF  THE INTRA-DAY AND INTER-DAY 
VARIABILITY IN EBC H2O2 CONCENTRATION AND pH 
 
4.1 Introduction 
 
Considerable variation in EBC H2O2 concentration has been described in 
human studies; an intra-day CV of over 40% in both healthy non-smoking 
humans and patients with asthma was reported by van Beurden et al. 
(2002). Despite this variability, a correlation between presence and 
severity of disease and EBC H2O2 concentration in humans has been 
reported (van Beurden et al. 2002a). These authors suggested this finding 
was consequent to the mean EBC H2O2 concentration in the population 
being relatively stable overtime. In contrast, EBC pH values in healthy 
humans have been found to be very stable overtime, with mean intraweek 
and intraday coefficients of variation of 4.5% and 3.5% respectively 
reported by Vaughan et al. (2003). Good correlation between degree of 
lower airway acidification and presence and severity of lower airway 
inflammation in humans has been reported (Hunt et al. 2000). 
 
The assessment of inter-day and intra-day variability in both EBC H2O2 
concentration and pH is essential for the validation of the use of these 
parameters as indicators of respiratory health/disease in horses. Variability 
of EBC H2O2 concentration measurements from horses after environmental 
challenge has been described by Deaton et al. (2005). In that study the 
variability reported was thought to be due to either physiological variation 
or a response of the airways to inhaled components of the air in the 
environment of the stable (Deaton et al. 2005a). In that study there was 
an increase in EBC H2O2 concentration in horses with RAO after 
environmental challenge. However, there were also changes in EBC H2O2 
concentration over a period of two weeks in both healthy and RAO horses 
following environmental challenge. The authors concluded that this 
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variability was the summation of the response to the challenge, 
experimental errors and inter-day physiological variation in EBC H2O2 
concentration (Deaton et al. 2005a). 
 
Exhaled breath condensate pH has not been studied previously in the 
horse. 
 
The aims of this study were to: 
1- assess the intra-day and inter-day variability of EBC H2O2 
concentration and pH in healthy horses and in horses with LAI; 
2- determine whether EBC H2O2 concentration and pH were 
associated with the health status of the respiratory tract (i.e. were 
there differences in these parameters between healthy horses and 
horses with LAI). 
 
4.2 Materials and Methods 
 
4.2.1 Animals 
 
Sixteen horses were used in the study and were divided into two groups. 
A control group comprised of eleven healthy horses free of any history or 
clinical signs of respiratory disease (4 mares, 7 geldings; 6 Cobs, 2 Ponies, 
2 Warmblood, 1 Thoroughbred cross; mean age: 12 years, ranging from 5 
to 20 years). Clinical examination findings of the control group horses, 
including auscultation during forced rebreathing, were within normal 
limits. Eight of the control horses lived at the same livery yard and each 
was stabled on wood shavings in a traditional stall and fed dry hay. The 
stable ceiling communicated between stalls and one window was opened 
at all times in each stall to provide ventilation. The remaining 3 horses of 
the control group were hospitalised at the Weipers Centre Equine 
Hospital, Faculty of Veterinary Medicine, University of Glasgow. These 
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horses were stabled on paper bedding in stalls with good ventilation and 
were fed soaked hay. None of the control group horses underwent 
anaesthesia or received any medication for at least 72 hours prior to or 
during the period of the study. 
 
The second group included five mares with lower airway inflammation 
(LAI). The LAI group was comprised of 2 Thoroughbred cross mares, 2 
Warmblood cross mares and 1 Pony mare. The mean age of the LAI 
horses was 16 years (range 6 to 24 years). Lower airway inflammation 
was confirmed by history, clinical signs (exercise intolerance, occasional 
cough and serous nasal discharge) and BALF cytology (neutrophils > 5%). 
The clinical examination and BALF cytology findings for each horse with 
LAI are summarised in table 4.1.  
 
Table 4.1: Clinical and bronchoalveolar lavage cytology data from 5 horses 
with lower airway inflammation 
 
 Signalment Clinical signs    BAL cytology 
Horse 1 
15 y.o. 
TB X 
Mare 
Occasional nasal discharge 
occasional cough 
Neutrophils 
Macrophages 
Lymphocytes 
Mast cells 
18% 
23% 
54% 
5% 
     
Horse 2 
22 y.o. 
TB X 
Mare 
Occasional cough 
Neutrophils 
Macrophages 
Lymphocytes 
Mast cells 
13% 
41% 
35% 
11% 
     
Horse 3 
24 y.o. 
Pony 
Mare 
Occasional cough, 
occasional nasal discharge 
Neutrophils 
Macrophages 
Lymphocytes 
Mast cells 
11% 
33% 
45% 
11% 
     
Horse 4 
15 y.o. 
WB X 
Mare 
Exercise intolerance 
prolonged recovery time 
from exercise 
occasional cough 
Neutrophils 
Macrophages 
Lymphocytes 
Mast cells 
15% 
30% 
50% 
5% 
     
Horse 5 
6 y.o. 
WB X 
Mare 
Cough 
increased inspiratory and 
expiratory effort 
bilateral nasal discharge 
Neutrophils 
Macrophages 
Lymphocytes 
Mast cells 
64% 
12% 
22% 
2% 
TB= thoroughbred, WB= Warmblood, X=cross, y.o=years old 
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The horses in the LAI group were stabled in stalls with good ventilation on 
paper bedding and fed soaked hay. None of the horses had received any 
medication in the previous 4 months. 
 
4.2.2 Collection of EBC Samples and Analysis 
 
The EBC samples were collected using the methodology described in 
paragraph 3.1. The collection time for each sample was 10 minutes. Each 
sample of EBC was stored on ice immediately after collection and thawed 
immediately prior to analysis. Hydrogen peroxide and pH were measured 
within one hour from collection as described in paragraph 3.2. 
 
4.2.3 Study design 
 
Intra-day variability of both EBC H2O2 concentration and pH was assessed 
by collection of EBC samples at 6 hourly intervals over a 12 hour period 
(6am, 12pm, 6pm) from each horse of both groups.  
 
To determine inter-day variability, a single EBC sample was obtained from 
each horse of both the control and LAI groups at 12pm daily for three 
consecutive days. 
 
4.2.4 Statistical analysis 
 
The mean coefficient of variation (CV) of intra-day and inter-day 
measurements of both H2O2 and pH were calculated for each of the 
control and LAI groups. For each group, the intra-day CV was calculated 
as the mean of the intra-day CV of each horse for both H2O2 and pH 
measurements. For each group the CV of inter-day measurements of H2O2 
and pH was obtained as the mean of the inter-day CV values for each of 
the horses in each group. Mean and standard deviation (SD) of H2O2 
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concentration and pH of both the control and LAI groups were calculated 
from all of the measurements for each group.  
 
A one-way ANOVA was used to detect significant differences of EBC H2O2 
concentration for intra-day variability and inter-day variability in both the 
control and LAI groups. Differences in both intra-day and inter-day EBC 
pH and differences in EBC H2O2 concentration and pH between control 
and LAI groups were assessed using the Mann-Whitney test. Relationship 
between EBC H2O2 concentration and pH was studied in both groups using 
the Pearson’s correlation rank. Significance was set at p<0.05. 
All studies were approved by the Animal Ethics and Welfare Committee of 
the Faculty of Veterinary Medicine, University of Glasgow. 
 
4.3 Results 
 
A total of 80 samples of EBC were collected from the 16 horses involved in 
the study. Hydrogen peroxide concentration was measured in all samples. 
pH was measured in 79 samples; measurement was not possible in one 
sample because insufficient EBC volume was retrieved. All horses 
tolerated the procedure of EBC collection. For the control group, the mean 
volume of EBC collected was 2.7±1.4ml and mean respiratory rate during 
collection was 10±3bpm. There was a tendency for a decrease in the 
respiratory rate with repeated collections. For the LAI group, the mean 
volume of EBC collected was 2.3±1.0ml and mean respiratory rate during 
collection was 12±4bpm. No significant differences were present between 
the two groups (in respiratory rates during collection or volume of EBC 
collected). The mean H2O2 concentration in the control group was 
2.3±1.8μM and 2.6±3.9μM in the LAI group. The mean pH in the control 
group was 6.00±0.61 and 5.77±0.26 in the LAI group. (Table 4.2). Data 
for each horse in each group are reported in Table 4.3 and in Table 4.4.  
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Table 4.2: Mean values (±SD) of all the measurements of H2O2 concentration 
and pH from the control and LAI groups 
 
   Control group  LAI group 
   Mean SD  Mean SD 
H2O2 (μM)  2.3 1.8  2.6 3.9 
pH  6.00 0.61  5.77 0.26 
 
 
Table 4.3: Coefficient of variation values for intra-day and inter-day 
measurements of both H2O2 concentration and pH in exhaled breath 
condensate from 11 horses without evidence of lower airway inflammation 
(control group). 
 
  Intra-day  Inter-day 
  H2O2 pH  H2O2 pH 
Horse 1  1.232 0.039  1.288 0.042 
Horse 2  0.330 0.004  0.573 0.007 
Horse 3  0.086 0.074  0.074 0.027 
Horse 4  0.505 0.072  0.932 0.072 
Horse 5  1.406 0.058  0.699 0.110 
Horse 6  0.391 0.042  0.697 0.085 
Horse 7  0.965 0.047  0.966 0.107 
Horse 8  0.497 0.107  0.552 0.053 
Horse 9  0.550 0.064  0.409 0.098 
Horse 10  0.997 0.028  0.780 0.061 
Horse 11  0.558 0.053  0.093 0.071 
Mean  0.683 0.053  0.642 0.067 
SD  0.409 0.027  0.364 0.033 
 
 
Table 4.4: Coefficient of variation values for intra-day and inter-day 
measurements of H2O2 concentration and pH in exhaled breath condensate of 
the 5 horses in the LAI group. 
 
  Intra-day  Inter-day 
  H2O2  pH   H2O2 pH 
Horse 1  0.243 0.042  1.084 0.004 
Horse 2  0.423 0.053  1.267 0.038 
Horse 3  1.732 0.026  1.100 0.047 
Horse 4  0.151 0.007  1.106 0.049 
Horse 5  0.458 0.058  0.597 0.055 
Mean  0.601 0.037  1.031 0.039 
SD  0.645 0.021  0.254 0.020 
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There was no significant difference in EBC H2O2 concentration (p=0.859) 
or pH (p=0.131) between the two groups. The calculated CV values for 
EBC H2O2 concentration and pH of the control group are shown in Table 
4.3. For the control group the mean CV for H2O2 concentration was 0.683 
and 0.64 for intra-day and inter-day measurements, respectively. In this 
group the calculated CV for EBC pH was 0.53 and 0.67 for intra-day and 
inter-day measurements, respectively. 
 
The calculated CV for the LAI group are shown in Table 4.4. For this 
group the CV for H2O2 concentration was 0.601 and 1.031 for intra-day 
and inter-day measurements, respectively. For EBC pH, the calculated CV 
was 0.37 and 0.39 for intra-day and inter-day measurements, 
respectively. 
 
The mean H2O2 concentration in the control group was 2.3±1.8μM and 
2.6±3.9μM in the LAI group. The mean pH in the control group was 
6.00±0.61 and 5.77±0.26 in the LAI group. There was no significant 
difference in EBC H2O2 concentration (p=0.859) or pH (p=0.131) between 
the two groups (Table 4.2).  
No significant difference in EBC H2O2 concentration for intra-day 
measurements was present in the control group (p=0.132) (Figure 4.1) or 
LAI group (p=0.475) (Figure 4.2). No significant inter-day difference in 
H2O2 concentration was present in the control group (p=0.088; Figure 
4.1). A significant difference in the inter-day repeated measurements of  
H2O2 concentration was present in the LAI group (p=0.019) (Figure 4.2).  
No significant difference in intra-day EBC pH measurements was present 
in the control group (p=0.572) (Figure 4.3; Table 4.5) or LAI group 
(p=0.811) (Table 4.6). No significant difference in inter-day EBC pH 
measurements was present in the control group (p=0.299) (Figure 4.3) or 
LAI group (p=0.231) (Table 4.5). No correlation was present between EBC 
H2O2 concentration and pH in the control group (Pearson’s correlation 
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coefficient=-0.127; p=0.354) (Figure 4.3) or LAI group (Pearson’s 
correlation coefficient=-0.277; p=0.181) (Figure 4.4). 
  
Table 4.5: Intra-day and inter-day EBC H2O2 concentration and pH collected on 
5 occasions over a 54 hour period from the horses in the control group (n=5) 
to assess intra-day variability (0hr, 6hr and 12 hr) and inter-day variability 
(6hr, 30hr and 54 hr).  
 
  H2O2 (μM)  pH 
  0h 6h 12h 30h 54h  0h 6h 12h 30h 54h 
Horse 1  1.8 1.2 0.3 0.0 0.1  5.84 5.58 5.47 5.90 5.92 
Horse 2  1.6 8.8 5.0 5.3 3.1  4.96 5.12 5.12 5.16 5.19 
Horse 3  3.2 3.1 3.7 3.6 3.7  5.24 5.69 5.02 5.02 5.28 
Horse 4  0.8 1.7 3.8 1.7 0.9  5.38 5.54 6.21 6.36 5.89 
Horse 5  1.6 0.6 3.9 0.0 1.0  5.91 6.34 6.32 5.82 7.30 
Horse 6  0.7 3.0 1.4 1.9 2.9  6.22 6.41 6.97 6.66 7.36 
Horse 7  0.4 0.6 1.1 0.0 3.5  5.89 5.78 5.82 6.28 7.01 
Horse 8  1.8 5.2 3.6 1.7 6.0  6.87 6.29 6.93 5.59 6.29 
Horse 9  1.4 2.6 2.5 0.7 1.2  5.49 5.46 6.20 5.77 6.69 
Horse 10  2.0 1.6 5.1 0.5 1.1  6.86 6.28 6.36 6.03 6.09 
Horse 11  2.5 4.0 2.6 1.1 3.0  5.79 6.38 6.36 5.80 6.67 
Mean  1.6 2.9 3.00 1.50 2.4  5.86 5.90 6.07 5.85 6.34 
SD  0.8 2.4 1.58 1.66 1.7  0.61 0.46 0.65 0.49 0.74 
 
Table 4.6: Intra-day and inter-day EBC H2O2 concentration and pH collected on 
5 occasions over a 54 hour period from the horses in the LAI group (n=5) to 
assess intra-day variability (0hr, 6hr and 12 hr) and inter-day variability (6hr, 
30hr and 54 hr). *= statistically significant (p=0.019) 
 
 H2O2 (μM) pH 
  0h 6h 12h 30h 54h 0h 6h 12h 30h 54h 
Horse 1 1.6 1.6 2.4 0.0 4.1 5.52 5.66 5.99 5.70 5.66 
Horse 2 1.9 2.1 3.9 1.2 14.9 5.38 5.61 5.97 6.05 5.80 
Horse 3 0.0 0.5 0.0 0.7 3.8 5.75 6.03 5.79 6.09 5.58 
Horse 4 1.7 1.6 3.6 0.0 4.3 5.99 6.07 5.43 6.29 5.71 
Horse 5 1.7 1.3 4.6 1.1 4.8 5.87 6.05 5.25 5.82 5.22 
Mean 1.37 1.87 2.44 0.60 6.38* 5.70 5.76 5.81 5.99 5.59 
SD 0.77 1.11 1.88 0.57 0.57 0.25 0.28 0.33 0.22 0.23 
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Figure 4.1: Box and whiskers quartile chart of H2O2 concentration in EBC of 
control horses (n=11) collected on 5 occasions over a 54 hour period to assess 
intra-day variability (0hr, 6hr and 12 hr) and inter-day variability (6hr, 30hr 
and 54 hr); *=mean 
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Figure 4.2: Box and whiskers quartile chart of the pH of EBC of control horses 
(n=11) collected on 5 occasions over a 54 hour period to assess intra-day 
variability (0hr, 6hr and 12 hr) and inter-day variability (6hr, 30 hr and 54 hr). 
No significant difference was present (p=0.299); *=mean. 
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Figure 4.3: Lack of correlation between EBC H2O2 concentration and pH in the 
horses of the control group (Pearson’s correlation coefficient=-0.127; 
p=0.354) 
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Figure 4.4: Lack of correlation between EBC H2O2 concentration and pH in the 
horses of the LAI group (Pearson’s correlation coefficient=-0.277; p=0.181) 
 
4.4 Discussion 
 
The results of this study demonstrate that within and between days there 
is a considerable variation in H2O2 concentration in EBC in both healthy 
horses and horses with LAI. The mean coefficient of variation in the LAI 
group was approximately double that of the control group. However,this 
difference was not statistically significant, probably due to the high 
variability present between horses in both groups. The variability in EBC 
H2O2 concentration observed in this study may partially explain the lack of 
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a significant increase of EBC H2O2 concentration after environmental 
challenge described in previous studies (Deaton et al. 2005a; Wyse et al. 
2005). Results of the intra-day and inter-day variability studies suggest 
that EBC H2O2 concentration is subject to wide fluctuations in individual 
horses. The use of one-way ANOVA identified a significant difference in 
the inter-day variation of H2O2 concentration in the five horses with LAI. 
Examination of the data suggest that the concentration of H2O2 was 
significantly greater on day 3 compared to days 1 and 2. There were no 
management changes during the period of the study that were likely to 
have exacerbated airway inflammation and the difference in EBC H2O2 
concentration is most probably consequence of the wide variability for 
repeated measurements and small number of horses in this group. 
Conversely, the inter-day variation was not significant in the control group 
and may reflect the larger number of horses in the control group in 
comparison to the LAI group. Inter-day variability of H2O2 concentration in 
the control group and LAI group could be due to effects of low 
grade/subclinical airway inflammation and/or different sensitivities of cells 
in the airways to environmental irritants or antigens. The number of 
neutrophils and other leukocytes that migrate into the airways as part of 
the physiology of the lower airways and the degree of activation of these 
cells may vary and influence the concentrations of H2O2 in EBC. In 
addition, the equipment used in this study and any methodological errors 
could induce some degree of variability in measured H2O2 concentration, 
however these were likely minimal as indicated by the results of the 
assessment of the methodology in paragraph 3.3. Differences in 
respiratory rates and flow rates of the horses could also have played a 
role in EBC H2O2 concentration variability. Expiratory flow rates have been 
shown to influence H2O2 concentration in human studies (Schleiss et al. 
2000). However, the influence of flow rates on EBC H2O2 concentration in 
horses has not been reported. In the current study EBC was collected 
during tidal breathing in all horses. In addition, it is possible that the 
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degree of environmental humidity and hydration status of the horses 
could have influenced results by influencing the dilution of constituents of 
EBC. The variability of H2O2 concentration in EBC in the current study (60-
103%) is higher than that reported for healthy humans (42%) and 
humans with chronic obstructive pulmonary disease (45%) (van Beurden 
et al. 2002a). In humans, variability in EBC H2O2 concentration is likely to 
be dependent on expiratory flow rates and circadian rhythms (Schleiss et 
al. 2000; Nowak et al. 2001; van Beurden et al. 2002a). Diurnal variation 
in EBC H2O2 concentration has not been studied in the horse and any 
diurnal effect in the current study is unknown. The large variability in H2O2 
concentration observed in the current study could explain the lack of 
significant difference between healthy horses and horses with LAI. 
 
The pH of EBC collected from horses has not been reported previously. 
The degree of variability in pH both within and between days in the 
horses of this study was low (≤ 6.7%) suggesting that EBC pH is largely 
unchanged over time. Similarly, minimal variability in EBC pH has been 
reported in human studies. In healthy human subjects the variation was 
3.5% and 4.5% for intra-day and intra-week repeated measurements, 
respectively (Vaughan et al. 2003). In the current study, some of the 
variation in EBC pH may have been contributed to by experimental/ 
methodological error. However, as discussed in paragraph 3.3, variability 
due to methodology was found to be approximately 1% for pH. The 
magnitude of the CV value for EBC pH in the current study are too high to 
be attributed only to experimental errors. In the absence of an 
appreciable change in the management of the horses, the variations in 
EBC H2O2 concentration and pH may represent physiological processes in 
the lower (and possibly upper) airways. 
 
The mean concentrations of H2O2 in EBC were slightly higher in LAI group 
compared to the control group, however no statistically significant 
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difference was detected. In addition, the pH of EBC was not significantly 
different between the two groups, although there was a slight trend for 
the control group to have a higher pH than the LAI group (p=0.13). The 
neutrophil differential count in the BAL of the LAI group was between 
11% and 18% in 4 of the 5 horses of this group suggesting mild 
inflammation. Only one horse had marked BALF neutrophilia (64%) 
consistent with marked inflammation. Hydrogen peroxide is produced by 
activated neutrophils and is possible that activation of airway neutrophils 
in the horses of the LAI group was limited as they were stabled in a low 
dust environment. Moreover the clinical signs of the horses in the LAI 
group were mild. Moderate exercise intolerance and prolonged recovery 
time after exercise were present in two horses, while the other three 
horses in this group had increased respiratory effort. Cytological 
examination of BALF was necessary to confirm the presence of LAI in 
these horses. It would have been preferable to perform a BAL and 
cytological analysis of BALF on each of the horses of the control group to 
exclude the presence of LAI and achieve a more objective differentiation 
between groups, however this procedure is invasive and it was not 
appropriate to perform on clinically healthy horses for ethics and welfare 
reasons. The absence of respiratory disease in the history of each horse 
and absence of clinical signs of LAI were considered acceptable to identify 
horses likely free of lower airway disease. It has been shown that 
examination of historical information can identify horses with RAO 
(Hotchkiss et al. 2006; Ramseyer et al. 2007), however this approach has 
not been assessed for the identification of horses with IAD, and it may be 
less sensitive in this disease group due to more subtle clinical signs. 
 
It is possible that inclusion of horses with more marked clinical signs of 
respiratory disease and greater airway inflammation would have produced 
a greater difference between control and LAI group for both for EBC H2O2 
concentration and pH. However, the wide variability in EBC H2O2 
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concentration may preclude the accurate identification of individual 
patients with LAI. It remains possible that quantification of EBC H2O2 may 
be a useful indicator of severity of LAI, as reported previously (Deaton et 
al. 2004b). While EBC pH had minimal variability within and between 
days, it was not a useful marker of mild LAI. Examination of horses with 
more marked LAI, for example acute RAO, may help to elucidate whether 
EBC pH is altered with airway inflammation. 
 
Another confounding factor in this study was that control and LAI groups 
were housed in two different environments. The management at the yard 
where the majority of the control horses were housed (8/11) was more 
traditional (wood shavings, dry hay diet) than that used to house the LAI 
group horses (paper bedding, good stable ventilation). Although no data 
on the quality of the air in the environment of the housing on the control 
horses were available, it is possible that the horses of this study were 
exposed to greater amounts of inhalatory antigens/allergens. If such 
exposure occurred, it may have caused mild inflammation of the lower 
airways of the healthy horses. In experimental settings, neutrophil 
percentage in BALF may mildly but significantly increase in healthy horses 
exposed to endotoxins and hay/straw challenge (Pirie et al. 2002). Such 
an increase in neutrophil percentage may be transient for only few hours 
(Pirie et al. 2002), however the activity of recruited cells is unknown. The 
horses in this study were not stabled on hay/straw bedding and a window 
was always opened to encourage ventilation of the stable, however there 
are no objective data to determine exposure to aeroallergens/antigens or 
endotoxins. Assessing the respiratory hygiene of the stable environment 
and in the breathing zone of the horses (eg. exposure to dust or 
endotoxin) was desirable and would have been beneficial for the current 
study, however equipment required for these investigations were not 
available for this study. In addition, ammonia (NH3) is commonly present 
in the environment of stables (Dixon et al. 1995b) and assessment of the 
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concentration of NH3 in the stable would have been useful to contribute to 
the understanding of EBC pH as it is possible that NH3 influences the acid-
base balance of the lower airways in horses as found previously in 
humans (Wells et al. 2005). The effect of respirable environmental factors 
on the lower airways of the horses in the control group is unknown as no 
BALF cytology was performed in these animals. 
 
Despite the limitations of the current study, the findings suggest that 
analysis of EBC H2O2 concentration and pH are not useful for detection of 
mild-moderate neutrophilic LAI. Further studies are required to determine 
whether quantification of H2O2 concentration and pH in EBC are useful for 
detection of more marked LAI. 
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CHAPTER 5 – CONCENTRATION OF H2O2 AND pH IN EBC OF 
HEALTHY HORSES AND HORSES WITH LAI 
 
5.1 Introduction 
 
Exhaled breath condensate (EBC) has been studied widely in human 
patients with inflammatory diseases of the lower airways, including 
asthma.  Numerous compounds are present in EBC from humans including 
hydrogen peroxide (H2O2), nitric oxides, adenosine, arachidonic acid 
metabolites, cytokines, leukotrienes, 8-isoprostane and ammonia (Horvath 
et al. 2005). Exhaled breath condensate H2O2 concentration is considered 
a suitable parameter for frequent monitoring of patients with respiratory 
disease such as asthma and COPD (Loukides et al. 1998; Loukides et al. 
2002; Horvath et al. 2005), despite the reported coefficient of variation for 
the parameter (van Beurden et al. 2002a). 
 
The concentration of H2O2 in EBC of horses with RAO has been reported; 
a significant relationship between the concentration of H2O2 in EBC and 
both the severity of clinical signs and BAL neutrophil count and ratio was 
found (Deaton et al. 2004b). In that study, the concentration of H2O2 in 
EBC was higher in affected horses during exacerbation of RAO than during 
a period of remission and also in comparison to healthy controls (Deaton 
et al. 2004b). However, in a subsequent study performed by the same 
authors, no relationship between concentration of H2O2 in EBC and 
presence of oxidative stress in the lower airways of RAO horses after 
environmental challenge was found and no significant increase in EBC 
H2O2 concentration in the horse was recorded (Deaton et al. 2005a). 
Similarly Wyse et al. (2005) found no significant difference in EBC H2O2 
concentration before and after environmental challenge in horses with 
RAO. The data presented in Chapter 4 of this thesis are suggestive of high 
variability in EBC H2O2 concentration in both healthy controls and horses 
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with mild LAI. Further in the study of Chapter 4, no significant difference 
was found in EBC H2O2 concentration between the control and LAI groups. 
Hydrogen peroxide is produced primarily by activated inflammatory cells in 
the airways as a consequence of oxidative stress (Babior 2000). In 
humans H2O2 is also produced by epithelial cells in the conducting airways 
and expiratory flow rates have been shown to influence its concentration 
in EBC (Schleiss et al. 2000). Potential limitations to the use of H2O2 for 
detection of LAI are that it is photo- and thermo-sensitive, extremely 
reactive towards a wide selection of materials and subject to rapid 
degradation. Further, a wide inter-day coefficient of variation for EBC H2O2 
in healthy humans has been reported (van Beurden et al. 2002a) and may 
be due to chemical reactivity and instability or circadian rhythms of H2O2 
secretion (Nowak et al. 2001). In contrast, other authors have described 
good correlation between EBC H2O2 concentration and the presence and 
severity of asthma in humans and response to treatment (Antczak et al. 
2000; Loukides et al. 2002). 
 
Similarly, EBC pH has been demonstrated to be a robust and reliable 
indicator of lower airway inflammation in humans affected by asthma or 
COPD (Kostikas et al. 2002; Vaughan et al. 2003; Borrill et al. 2005). In 
addition, the degree of acidification in the lower airways has been shown 
to be correlated to the presence and severity of asthma in affected human 
patients (Hunt et al. 2000). Acidification of the lower airway lining fluid 
detected in EBC appears to be implicated in the pathophysiology of 
asthma in humans, as a low pH may predispose to asthma and reflects an 
abnormality in the regulation of non-volatile constituents in the lower 
airways (Hunt et al. 2000). The pH of EBC in healthy humans has been 
found to be very stable overtime with reported mean intraweek and 
intraday coefficients of variation of 4.5% and 3.5% (Vaughan et al. 2003). 
It is unknown whether there is an association between pH of EBC and the 
health/disease status of the lower airways of horses. 
 86
 The aims of this study were: 
1. to determine whether significant differences in EBC H2O2 
concentration and pH are present between healthy horses and 
horses with LAI (as defined by increased neutrophil percentage in 
BALF) 
2. to investigate if a relationship between H2O2 concentration and pH 
in EBC exists in both healthy horses and horses with LAI. It is 
possible that an increase in H2O2 concentration may indicate 
oxidative stress and be related to acidification of the BALF as 
suggested in studies of human asthma (Hunt et al. 2000).  
 
5.2 Materials and Methods 
 
5.2.1 Animals 
 
Thirty-one horses were used in the study. Horses were divided into three 
groups depending on housing and respiratory tract health as determined 
by the presence or absence of a history consistent with LAI, with/without 
BALF cytology results. 
Group 1: a stable control group comprised of 19 horses (5 mares, 14 
geldings; 9 Cobs, 4 Warmblood, 3 Ponies, 2 Thoroughbred crosses, 1 
Anglo-arab cross; age: 11±5 years) that did not have a history of 
respiratory disease. All horses underwent thorough clinical examination, 
including auscultation of the lungs during forced rebreathing. No abnormal 
bronchoalveolar or tracheal sounds were detected in any horse (apart 
from #9 and #13 which were subsequently excluded from the study). 
Broncho-alveolar lavage was not performed for ethics and welfare 
reasons. Fourteen horses were from the same yard and were stabled on 
wood shavings in a traditional stall, where the ceiling communicated 
between stalls and the upper section of the stable door was opened at all 
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times to maximise ventilation. The remaining five horses of the group 
were stabled in modern stables with good ventilation on paper bedding 
and were fed soaked hay. None of the horses had received any 
medication during the previous 4 months. In addition, the horses were not 
administered any medications for at least 72 hours prior to the beginning 
of the study, as declared by the owners. Signalment and management 
data for the horses in this group are provided in Table 5.1. 
 
Table 5.1: Signalment, stable bedding used and feeding of control horses 
housed in stables 
 
  Age (years) Gender  Breed Bedding Diet 
Horse 1 15 M TB X Paper Soaked hay 
Horse 2 5 G TB X Paper Soaked hay 
Horse 3 4 G WB X Paper Soaked hay 
Horse 4 16 G Pony Wood-shavings Dry hay 
Horse 5 7 G Cob X Wood-shavings Dry hay 
Horse 6 6 G Cob X Wood-shavings Dry hay 
Horse 7 12 G Irish Cob Wood-shavings Dry hay 
Horse 8 15 G Welsh Cob X Wood-shavings Dry hay 
Horse 9 11 G Anglo-Arab X Wood-shavings Dry hay 
Horse 10 11 M Cob X Wood-shavings Dry hay 
Horse 11 6 G Belgian WB Wood-shavings Dry hay 
Horse 12 12 G Pony Wood-shavings Dry hay 
Horse 13 20 G Welsh Cob X Wood-shavings Dry hay 
Horse 14 19 M Welsh Cob X Wood-shavings Dry hay 
Horse 15 7 M WB X Wood-shavings Dry hay 
Horse 16 5 G Welsh Cob X Wood-shavings Dry hay 
Horse 17 20 G Cob X Wood-shavings Dry hay 
Horse 18 8 G Pony Paper Soaked hay 
Horse 19 9 M WB X Paper Soaked hay 
G=gelding; M=mare; TB= Thoroughbred; WB=Warmblood; X=cross 
 
Group 2: A pasture control group included four healthy horses (2 mares 
and 2 geldings; 2 Warmblood and 2 New-forest ponies; age 5±3 years) 
that lived on pasture at least 12 hours a day (Table 5.2). These horses did 
not have a history consistent with LAI and no evidence of LAI was 
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detected during physical examination, including auscultation of the lungs 
during forced rebreathing. Broncho-alveolar lavage was not performed 
from the horses of this group for ethics and welfare reasons. For all 
horses, EBC was collected immediately after return from pasture. None of 
the horses had received any medication during the previous 4 months. In 
addition, the horses were not administered any therapeutic preparation for 
at least 72 hours prior to the beginning of the study, as declared by the 
owners. 
 
 
Table 5.2: Signalment and housing of pastured control horses  
 
 Age Gender Breed Pasture 
Horse 20 10 Gelding Warmblood 12h/day 
Horse 21 4 Mare Warmblood 12h/day 
Horse 22 2 Gelding New-Forest pony 24h/day 
Horse 23 4 Mare New-Forest pony 24h/day 
 
 
 
Group 3:  this group comprised of horses with LAI (LAI group) and 
included 8 horses (6 mares and 2 geldings; 3 ponies, 2 Thoroughbred 
crosses, 3 Warmblood crosses; age: 14±6 years). Lower airway 
inflammation was confirmed by history, clinical signs (cough, exercise 
intolerance and nasal discharge) and BALF cytology (neutrophils > 5%). 
Horses were stabled on paper bedding and fed soaked hay, in stalls with 
good ventilation. 
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Table 5.3: Signalment, history, clinical signs and BALF cytology of horses with 
lower airway inflammation (LAI group) 
 
Signalment  . History and clinical signs BAL cytology 
Neutrophils 18%
Macrophages 23%
Lymphocytes 54%
Horse 
24 
TB X 
Mare 
15 yo 
Nasal discharge 
occasional cough 
Mast cells 5%
     
Neutrophils 13%
Macrophages 41%
Lymphocytes 35%
Horse 
25 
Pony 
Mare 
22 yo 
Occasional cough 
prolonged recovery time 
from exercise 
Mast cells 11%
     
Neutrophils 11%
Macrophages 33%
Lymphocytes 45%
Horse 
26 
TB X 
Mare 
24 yo 
Occasional cough 
nasal discharge 
Mast cells 1%
     
Neutrophils 15%
Macrophages 30%
Lymphocytes 50%
Horse 
27 
WB X 
Mare 
13 yo 
Exercise intolerance 
prolonged recovery time 
from exercise 
occasional cough Mast cells 5%
     
Neutrophils 29%
Macrophages 36%
Lymphocytes 26%
Horse 
28 
WB X 
Geld 
11 yo 
Cough 
RAO exacerbation (12h earlier) 
received IV Dexamethasone 
increased expiratory effort Mast cells 6%
     
Neutrophils 22%
Macrophages 6%
Lymphocytes 62%
Horse 
29 
NF 
Pony 
Geld 
14 yo 
RAO previously diagnosed 
ended inhalatory steroid 
treatment (2 weeks earlier) 
in remission Mast cells 10%
     
Neutrophils 8%
Macrophages 24%
Lymphocytes 60%
Horse 
30 
NF 
Pony 
Mare 
9 yo 
RAO previously diagnosed 
ended inhalatory steroid 
treatment (2 weeks earlier) 
in remission Mast cells 8%
     
Neutrophils 64%
Macrophages 19%
Lymphocytes 14%
Horse 
31 
WB X  
Mare 
6 yo 
Increased respiratory effort 
tachypnea 
cough 
nasal discharge Mast cells 3%
RAO= recurrent airway obstruction; TB=Throughbred; WB=Warmblood; NF= New 
Forest; y.o.=years old  
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 5.2.2 Collection of EBC Samples and Analysis 
 
Stable and Pasture control groups: One EBC was collected from each 
horse using the methods described in paragraph 2.1. Each sample was 
collected over a period of 10 minutes, stored immediately on ice after 
collection and thawed immediately prior to analysis. Concentration of H2O2 
and pH in each sample were determined within one hour of collection.  
LAI group: presence of LAI was confirmed by BAL cytological examination. 
Exhaled breath condensate was collected immediately prior to the BAL 
procedure and the collected sample was stored immediately on ice. 
Concentration of H2O2 and pH in each sample were determined within one 
hour of collection. 
 
5.2.3 Statistical analysis 
 
One-way ANOVA was used to detect significant differences (p<0.05) in 
EBC H2O2 concentration, EBC pH, respiratory rate and EBC volume 
collected between the three groups. Pearson’s correlation coefficients 
were calculated to determine whether correlations between EBC H2O2, 
EBC pH, horse age, EBC volume produced and horse respiratory rate were 
present. Relationships between BAL neutrophil ratio and EBC H2O2 
concentration and pH were studied in the LAI group using the Pearson’s 
correlation rank. For the calculation of the Pearson’s correlation 
coefficients stable control group and pasture control group are combined 
in a unique group. 
 
5.3 Results 
A total of 31 samples of EBC were collected (1 sample from each horse in 
the study). A tracheal rattle was heard in two horses in the stable control 
group during forced rebreathing and the EBC samples from these two 
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horses were excluded from the study (Table 5.6). Sample collection was 
tolerated by all horses in the study except horse 10 where the procedure 
was suspended after 5 minutes (0.6ml collected) because the horse 
became excited and developed a markedly raises respiratory rate 
(>30breaths/min) and an irregular respiratory rhythm. No significant 
difference was present between groups for respiratory rates during 
collection (p=0.734) or volume (p=0.841) of EBC collected (Table 5.4). 
 
Table 5.4: Mean and standard deviation (SD) of respiratory rate and volume of 
EBC collected from the Stable control group, Pasture control group and lower 
airway inflammation (LAI) group. 
 
  Respiratory Rate (brpm) Volume collected (ml) 
 Mean SD Mean SD 
Stable control group 14 5 2.0 1.3 
Pasture control group 13 3 1.8 0.2 
LAI group 15 4 1.6 1.1 
 
 
The mean (±SD)  EBC H2O2 concentration was 4.0±2.9μM  (median: 
3.3μM, range: 0.9-12.9μM) in the stable control group, 3.3±0.5μM 
(median: 3.3μM, range: 2.6-5.4μM) in the pasture control group and 
3.9±3.0μM (median: 2.94μM, range: 9.7-0.9μM)  in the LAI group. The 
mean ± standard deviation EBC pH was 5.77±0.55 (median: 5.77, range: 
6.70-4.78) in the stable control group, 5.72±0.21 (median: 5.80, range: 
5.41-5.88) in the pasture control group and 5.31±0.62 (median: 5.38, 
range: 4.41-6.10) in the LAI group (Table 5.5). 
 
Table 5.5:  Mean and SD of H2O2 concentration and pH of EBC collected from 
the Stable control group, Pasture control group and lower airway 
inflammation (LAI) group 
 
  H2O2 (μM)  pH 
 Mean SD Mean SD 
Stable control group 4.0 2.9 5.77 0.55 
Pasture control group 3.3 0.5 5.72 0.21 
LAI group 3.9 3.0 5.31 0.62 
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No significant difference was found between groups for EBC H2O2 
concentration (p=0.895) (Figure 5.1) or EBC pH (p=0.188) (Figure 5.2). 
Summary data of EBC H2O2 concentration and pH for each group are 
provided in Table 5.5. Data of EBC H2O2 concentration and pH for each 
horse is provided in Table 5.6. 
Table 5.6: EBC H2O2 concentration and pH, respiratory rate (RR; breaths per 
minute) and volume of EBC collected from the Stable control group, Pasture 
control group and horses in the group with lower airway inflammation (LAI) 
(*: horses 9 and 13 were excluded for detection of abnormal tracheal sound 
during auscultation) 
GROUP HORSE H2O2 (μM) pH RR Volume (ml) 
Horse 1 7.7 4.95 8 2.5 
Horse 2 4.4 5.49 15 2.0 
Horse 3 4.8 4.78 13 0.8 
Horse 4 2.9 5.81 12 1.0 
Horse 5 12.9 5.55 10 0.8 
Horse 6 3.4 5.70 10 1.0 
Horse 7 1.5 5.75 8 1.5 
Horse 8 2.3 5.77 10 1.5 
Horse 9* 10.8 5.48 14 0.8 
Horse 10 4.1 6.40 24 0.6 
Horse 11 0.9 5.86 10 0.8 
Horse 12 1.4 6.59 24 1.0 
Horse 13* 6.4 6.40 16 1.8 
Horse 14 3.1 5.83 12 1.5 
Horse 15 3.3 6.70 22 3.0 
Horse 16 5.4 6.33 16 3.0 
Horse 17 6.0 6.12 14 3.5 
Horse 18 1.4 5.15 16 2.8 
Stable 
Control 
Group 
Horse 19 3.2 5.24 10 4.8 
      
Horse 20 3.4 5.82 8 1.7 
Horse 21 3.5 5.41 12 1.7 
Horse 22 3.8 5.88 14 1.7 
Pasture 
control 
group 
Horse 23 2.6 5.78 16 2.1 
      
Horse 24 0.9 5.53 8 1.5 
Horse 25 2.4 5.64 12 1.0 
Horse 26 9.7 5.83 20 4.0 
Horse 27 3.3 6.10 12 1.8 
Horse 28 6.3 4.85 18 1.0 
Horse 29 2.4 4.84 18 0.5 
Horse 30 2.6 4.41 16 1.4 
LAI group 
Horse 31 4.8 5.22 20 3.0 
 93
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
Pasture control
group
Stable control
group
LAI group
H
2
O
2
 (
μ
M
)
 
Figure 5.1: Boxplot of EBC H2O2 concentration for each group; no statistically 
significant difference between groups was present (p=0.895); *= mean 
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Figure 5.2: Boxplot of EBC pH of the pasture control group, stable control 
group and lower airway inflammation group; no significant difference 
between the three groups was detected (p=0.188); *= mean  
 
Figure 5.3 and Figure 5.4 demonstrate the distribution of EBC pH and 
H2O2 concentration in the control and LAI groups respectively. No 
significant correlation was found between concentration of H2O2 and pH in 
EBC obtained from healthy horses at pasture or in stables (Figure 5.3) and 
horses with LAI (Figure 5.4). 
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Figure 5.3: Distribution of H2O2 concentration and pH in EBC of healthy horses; 
there was no correlation between H2O2 concentration and pH (Pearson’s 
correlation coefficient=-0.205; p=0.372) 
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Figure 5.4: Distribution of H2O2 concentration and pH and trend line in horses 
with lower airway inflammation; no correlation was detected (Pearson’s 
correlation coefficient=0.183; p=0.665)  
 
Data regarding the results of Pearson’s correlation analyses for healthy 
horses and horses with LAI are provided in Tables 5.7 and 5.8 
respectively. The only significant correlation was between EBC pH and 
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respiratory rate in healthy horses (Pearson’s correlation coefficient=0.631; 
p=0.002) (Figure 4.5). 
 
 
Table 5.7: Pearson’s correlation coefficient for variables in healthy horses; 
*:statistically significant 
 
Pasture control group, stable control group 
 Resp Rate Volume H2O2 pH 
Age -0.113 0.667 
0.083 
0.055 
-0.006 
p=0.980 
0.145 
p=0.530 
     
Resp Rate  0.033 p=0.868 
-0.001 
p=0.996 
0.631 
p=0.002* 
     
Volume   -0.182 p=0.430 
-0.063 
p=0.785 
     
H2O2    
-0.205 
p=0.372 
 
 
 
Table 5.8: Pearson’s correlation coefficient for variables in horses with lower 
airway inflammation 
 
LAI group 
 Resp Rate Volume H2O2 pH 
Age -0.176 0.920 
0.204 
0.770 
0.419 
p=0.349 
0.635 
p=0.125 
     
Resp Rate  0.033 p=0.868 
0.752 
p=0.051 
0.502 
p=0.251 
     
Volume   0.739 p=0.057 
-0.375 
p=0.487 
     
H2O2    
0.191 
p=0.682 
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Figure 5.5: Relationship between respiratory rate and EBC pH in healthy 
horses; a significant relationship was detected using a Pearson’s correlation 
coefficient (0.631; p=0.002). 
 
5.4 Discussion 
 
No significant differences in either EBC H2O2 concentration or pH were 
found between the three groups of horses in the current study. In 
contrast, Deaton et al. (2004) found that horses with RAO had a 
significantly higher concentration of  H2O2 in EBC than healthy control 
horses. In the study by Deaton et al. (2004) horses with severe clinical 
signs of RAO were used. In the current study horses with LAI had mild 
clinical signs and may explain the lack of a difference in EBC H2O2 
concentration in EBC between healthy horses and horses with LAI. In 
humans, H2O2 concentration in EBC appears to be a useful marker of 
airway inflammation. A significant correlation between EBC H2O2 
concentration and severity of asthma has been documented (Loukides et 
al. 2002; Kharitonov and Barnes 2004). Asthmatic children have a lower 
concentration of H2O2 in EBC during remission or following treatment with 
corticosteroids, compared to the acute phase of the disease (Kharitonov 
and Barnes 2004). 
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 It would have been preferable to have performed BAL in the control 
horses of the current study to allow more objective differentiation 
between control and LAI groups by the use of respiratory cytology rather 
than sole reliance on history and physical examination. It is possible that 
some horses in the stable or pasture control groups had subclinical LAI 
that was not detected by history and physical examination alone. 
However, for ethics and welfare reasons, BAL was not performed in 
healthy horses. The absence of respiratory disease in the history of each 
horse and absence of clinical signs of LAI were considered acceptable to 
identify horses likely free of lower airway disease. It has been shown that 
examination of historical information can identify horses with RAO 
(Hotchkiss et al. 2006; Ramseyer et al. 2007), however this approach is 
likely to be less sensitive to identify those horses with IAD. In addition, it 
is possible that one or more of the control horses that had high H2O2 
concentration or low pH in EBC could have had an upper airway disease 
(e.g. sinusitis, pharyngitis, laryngitis) that altered these parameters. 
Human patients with sinusitis have been found to have increased EBC 
H2O2 concentration for up to two weeks following resolution of clinical 
signs (Jobsis et al. 2001). The effect of upper airway pathology on EBC 
H2O2 and pH, the site of production of H2O2 detected in EBC and the 
proportion of H2O2 produced from the upper and lower respiratory tract in 
the horse are all unknown. While no evidence of upper respiratory tract 
disease was detected on physical examination, upper airway endoscopy 
and radiography were not performed in control horses. Moreover, the 
horses in the LAI group showed only mild clinical signs of LAI, namely 
nasal discharge, occasional cough and/or prolonged recovery time from 
exercise. No increased respiratory effort at rest was present and a mild 
seromucous nasal discharge was the only clinical abnormality in some 
horses. Two horses with a history of RAO had no clinical signs at the time 
of collection of EBC and BALF (BAL was performed as a component of 
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clinical reassessment after prior diagnosis of the disease). It is possible 
that these factors, individually or collectively, reduced the differences in 
H2O2 concentration and pH of EBC between control horses and horses 
with LAI. Further, it is possible that including horses with more severe 
clinical signs may have resulted in significant differences in EBC H2O2 and 
pH between groups as reported by Deaton et al (2004a). 
 
Collection of EBC was tolerated well by all but one of the horses. One 
mare did not tolerate prolonged breathing through the mask possibly as a 
result of the noise generated by the movement of the one-way valve of 
the mask adjacent to the nose of the horse. After 5 minutes the procedure 
was discontinued as the excitation of the horse caused a marked increase 
in the respiratory rate (>30) with an irregular rhythm. Some horses in the 
study required a few minutes to get accustomed to the mask and EBC 
collection was commenced when the respiratory rates returned to the rate 
prior to application of the mask. In most situations one operator was 
sufficient to undertake EBC collection from the horses as the sampling 
procedure was simple and easy to perform. As reported in human studies 
of EBC collection (Griese et al. 2001; Mutlu et al. 2001) ease of collection 
is an advantage of this methodology that justifies studies of EBC analysis 
in relation to respiratory disease in horses. 
 
An increase in the respiratory rate was considered the main indicator of 
horse distress during EBC collection in the current study. In human 
patients flow-dependency of H2O2 production has been determined, 
suggesting that H2O2 is produced also by the epithelial cells of the 
conducting airways (Schleiss et al. 2000). Although there is limited 
knowledge concerning the production of H2O2 in the equine airways, 
collection of EBC at tidal breathing was attempted in the current study. 
Further studies are required to assess whether expiratory flow rates can 
influence H2O2 production in equine species.  
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 The EBC pH in the horses of the current study (mean±SD: 5.76±0.5, 
median: 5.78, range: 4.78-6.70 in healthy horses) was, on average, lower 
than ranges reported for plain samples from human patients with asthma 
(median: 6.46, range: 5.86-6.72) and healthy humans (usually greater 
than 7) (Leung et al. 2006). In the current study there was no statistically 
significant difference in EBC pH between stabled control, pasture control 
and LAI groups by the use of ANOVA (p=0.188). It is possible that the 
horses comprising the 3 groups did not have sufficient differences in 
airway health to induce appreciable changes in EBC pH. Whether including 
horses with more severe clinical signs of LAI and using control horses with 
confirmed normal respiratory cytology would increase the likelihood of 
significant differences in EBC pH, remains to be established. Studies in 
human medicine reported a significantly lower pH in patients affected by 
disease such as asthma (Hunt et al. 2000), COPD, bronchiectasis (Kostikas 
et al. 2002), cystic fibrosis (Tate et al. 2002), and acute lung injury 
(Gessner et al. 2003) compared to healthy controls. The effect inhalation 
of ammonia present in the air of the horses environment has on EBC pH is 
unknown and requires clarification. Contamination of EBC with oral 
ammonia is of concern to human investigators and the recommendation is 
to incorporate a saliva trap in the collection device to minimize 
contamination of EBC samples with oral ammonia and if a saliva trap is 
not used, the ammonia concentration in EBC should be evaluated (Effros 
et al. 2002; Horvath et al. 2005). However, determining the concentration 
of ammonia in inspired/expired air was beyond the scope of the current 
study.  
 
A significant correlation between EBC pH and respiratory rate in the 
control horses was determined by linear regression analysis (p=0.002). In 
three control horses the respiratory rate increased slightly (just over 20 
breaths/minute) due likely to mild excitement. In these horses the pH of 
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EBC was higher than in horses with a lower respiratory rate and this likely 
contributed to the observed correlation. In humans, no relationship 
between respiratory pattern and EBC pH has been found, suggesting that 
flow dependency for EBC pH does not occur (Vaughan et al. 2003). In the 
current study, EBC pH and respiratory rates in horses with LAI were not 
correlated. Hydrogen peroxide concentration in EBC was not significantly 
correlated to the respiratory rate during EBC collection (p=0.051) and 
volume of EBC collected (p=0.057) in the LAI group, however trends were 
present. The trend between EBC H2O2 concentration and respiratory rate 
may suggest that EBC H2O2 concentration may be flow dependent, 
however numbers of horses in the study were limited. Utilisation of 
greater numbers of horses and inclusion of greater diversity of respiratory 
rates (e.g. before and after moderate exercise) may provide useful data to 
establish if H2O2 concentration and pH in EBC are flow dependent. 
Recently, moderate intensity exercise was shown to cause a significant 
increase in EBC pH in healthy humans (Riediker and Danuser 2007) and it 
was speculated that exercise can induce oxidative stress on the lower 
airways. The effect of exercise on EBC pH in healthy horses and horses 
with LAI is unknown. However, exercise in horses, particularly when 
breathing cold, dry air can lead to lower airway inflammation (Davis et al. 
2007). It remains possible the effect of exercise in horses could be 
assessed by measuring EBC H2O2 concentration and pH, if the effect of 
exercise are sufficient to trigger an inflammatory response in the lower 
airways. However, it would remain difficult to assess whether 
inflammation is a consequence of exercise or if there is a flow dependency 
of H2O2 and pH when using exercise. 
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 CHAPTER 6 – GENERAL DISCUSSION AND CONCLUSIONS 
 
6.1 Collection and Analysis of EBC in Horses 
 
The results of the current studies indicate that the equipment and 
methodology used to collect EBC from standing non-sedated horses were 
reliable and repeatable. The equipment used is portable and suitable for 
stable-side collection and was adapted from that described by Wyse et al. 
(2005). The methodology for collection of EBC is simple and a single 
operator was sufficient to undertake EBC collection from the horses. All 
but one horse involved in the study tolerated the collection procedure. 
Overall, horses appeared to become more accustomed to the collection 
procedure with successive collections. Respiratory rate and rhythm of 
horses were minimally or not affected by the procedure. In addition to the 
minimal personnel requirements for collection of EBC, in the current study 
there was no requirement for physical or chemical restraint of any horse. 
A total of 121 samples from 33 horses were collected throughout the 
course of the study, suggesting the method used was safe, rapid and 
simple. Documentation of respiratory rate of each horse and collection of 
the EBC sample during basal respiration were considered important 
because H2O2 concentration in EBC is potentially influenced by respiratory 
flow rates as suggested by human studies (Schleiss et al. 2000). Flow-
dependency of H2O2 production in EBC of human patients has been 
documented, suggesting that a portion of H2O2 is produced by the 
epithelial cells of the conducting airways during periods of increased air-
flow (Schleiss et al. 2000). The internal diameter of the tubing used to 
collect EBC was approximately 5cm and two valves were used to minimize 
resistance to airflow in the system. Increased breathing resistance could 
have potentially caused distress in some animals and affected respiratory 
flow rates. On account of the unchanged behaviour and unaffected 
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respiratory rates of the horses during the sampling procedure it is 
concluded that this technique is very well tolerated and is suitable for EBC 
stall side collection. The materials used to build the collection system were 
chosen for their inert properties. The condensation chamber was 
constructed of polypropylene, in compliance to the official 
recommendation for EBC collection (Horvath et al. 2005). The disinfection 
protocol used throughout the study was evaluated and found not to affect 
the concentration of H2O2 or the pH. 
 
The gold standard for the assessment of LAI in horses is cytological 
examination of BALF (Christley and Rush 2007; Lavoie 2007). 
Bronchoalveolar lavage is an invasive procedure, requires sedation and 
physical restraint of the horse and can causes irritation of the respiratory 
tract. Horses may cough violently and demonstrate signs of discomfort 
during the procedure. Although the irritation (and occasionally distress) of 
this procedure can be alleviated by sedation and instillation of local 
anaesthetic in the lumen of the trachea, many horses still cough during 
the procedure. The trauma induced by the passage of the BAL 
tube/endoscope and lavage with saline may induce inflammation of the 
lower airways. The procedure can stimulate the migration of inflammatory 
cells into the airways and result in an increase in neutrophil percentage in 
repeated BAL samples obtained from the same lung segment at least 48 
hours later (Sweeney et al. 1994). Sweeney et al. (1994) reported that 
neutrophil percentage in BALF from healthy horses increased from a mean 
of 2.3% at the initial sample to a mean of 27.3% in a second sample 
obtained 48 hours later. This finding suggests that BAL is not suitable for 
short term monitoring of lower airway health in horses both from a 
welfare perspective and because of difficulties in interpreting cytological 
results. A further limitation of cytologic examination of BALF is that while 
evidence of the number of inflammatory cells (principally neutrophils) in 
the lower airways is provided, it does not give any information regarding 
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the activation status of inflammatory cells. A potential advantage of EBC 
analysis is that evidence of the functional activity of granulocytes may be 
obtained. Furthermore, due to the non-invasive nature of the procedure, 
collecting multiple EBC samples over a short period of time will not result 
in any airway inflammation; hence EBC analysis is suitable for frequent 
sampling and may prove ideal for monitoring horses with respiratory 
disease (Wyse et al. 2005). 
 
The hazard related to the use of liquid nitrogen is a possible limitation of 
the practicality of EBC collection due to specific requirements for handling 
of liquid nitrogen. In the current study, liquid nitrogen was chosen to 
obtain the lowest possible temperature in the condensation chamber. 
Liquid nitrogen needs to be handled with considerable caution to avoid 
contact with the skin of personnel and horses. The fumes of liquid 
nitrogen can be harmful and the liquid must be handled in an environment 
with good air circulation. Furthermore, liquid nitrogen is not necessarily 
accessible and there are considerable security issues related to its 
transport. However, many veterinary surgeons are equipped for its 
transportation since it is widely used, e.g. to preserve frozen semen and 
for cryotherapy. In the current study liquid nitrogen was mixed with 
ethanol because ethanol remains as a liquid at very low temperatures 
(melting point -114.3°C), is inexpensive and is readily available. The 
rationale to mix liquid nitrogen and ethanol is that the obtained slush did 
not produce any fumes and maintained the required temperature range 
for several hours (after 3 hours at room temperature, the temperature of 
the slush in the polystyrene container was still less than -80˚C). In 
addition, these low temperatures were chosen to maximize the volume of 
EBC collected over a period of ten minutes. Further, this collection 
temperature is in compliance with the official recommendation to freeze 
samples at ≤ -70˚C immediately after collection until analysed (Horvath et 
al. 2005), as lower temperatures achieve a better preservation of H2O2 
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(van Beurden et al. 2002b). In preliminary studies, temperatures achieved 
using ice to surround the condensation chamber were found to be 
insufficient for EBC collection (less than 0.4ml of EBC were obtained), 
while the liquid nitrogen/ethanol mixture allowed collection of an 
adequate volume of EBC for laboratory analysis of both H2O2 and pH. 
 
The concentration of H2O2 detected in the EBC samples of the current 
study tended to be higher than those reported in other studies performed 
in horses (Deaton et al. 2004a; Wyse et al. 2005; Deaton 2006). In the 
studies by Deaton et al. (2004a) the temperature of the collection 
chamber was ~0°C and the use of different temperatures for the collection 
has been found to affect EBC H2O2 concentration (Goldoni et al. 2005). 
The difference between this study and the study of Deaton et al. (2004a) 
could be due to different collection temperatures. It is possible that using 
a low temperature (≤ -80˚C) improves the preservation of H2O2 and may 
be preferable for collection of EBC. However, the effect of collection 
temperature and EBC H2O2 concentration has been studied in human 
patients and a decreased H2O2 concentration in samples collected at lower 
temperatures (at -10˚C compared to +5˚C) was reported, possibly due to 
dilutional effects of a larger volume of EBC collected at the lower 
temperature (Goldoni et al. 2005). However, in humans the absolute 
amount of H2O2, obtained by multiplying its concentration by the total 
volume of EBC, was higher collecting at lower temperatures (Goldoni et al. 
2005). The effect of collection temperature on measured H2O2 
concentration in EBC samples is unknown and was not investigated in the 
current study. It is unlikely the difference in H2O2 concentration between 
the current study and that of Deaton et al. (2004a) was due to 
methodological differences in the protocol for the quantification of H2O2, 
as the assay used between these studies was the same. 
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The results of the studies discussed in Chapter 2 indicate that the 
measurement of the pH of EBC can be problematic as a period of up to 20 
minutes may be required to obtain a stable reading. In human medicine 
the instability of the EBC pH is well recognised and is attributed to volatile 
substances present in EBC (Hunt et al. 2000). Carbon dioxide is believed 
to be the main cause of instability, but there is no official recommendation 
in human medicine as to whether pH of EBC should be measured with or 
without deaeration (Horvath et al. 2005). Some authors have attempted 
to standardise for CO2 partial pressure and reported a better stability than 
that achieved by deaeration with argon (Kullmann et al. 2007). In the 
current study various methods of stabilising the reading of EBC pH were 
studied. Those obtained from the plain samples were the most repeatable 
and reliable in comparison to human studies where deaeration with argon 
or standardisation with CO2 give the most repeatable measurements 
(Borrill et al. 2006; Kullmann et al. 2007). This method was selected for 
subsequent investigation in the current study. Determination of all the 
components present in equine EBC would be useful as this would allow a 
better understanding of the mechanisms leading to instability of pH and 
whether any interactions between components are likely to occur. 
However, such investigation were beyond the scope of the current study. 
 
A polypropylene (PP) condensation chamber was a component of the 
equipment used in the current study. Polypropylene is an established 
material for EBC collection in human medicine (Horvath et al. 2005). This 
material is a hypo-reactive plastic that is very stable at high and very low 
temperatures. In addition, PP is ideal for stall-side collection, as it is light, 
impermeable and resistant to breakage. In contrast, a glass or pyrex 
chamber would be susceptible to breaking and if breakage occurred this 
could compromise the safety of the operator or of the horse. 
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The method of collection used in the current studies could also be useful 
to investigate other markers of inflammation (e.g. cytokines, leukotrienes, 
ammonia, nitric oxides, proteins, etc.) that have not been investigated in 
equine EBC to date. In human studies expression of many markers of 
inflammation (IL-4, IL-6, IL-8, γ-INF, 8-isoprostane) and other substances 
(ammonia, CO2, carbonic acid, lactate) in EBC has been correlated with 
the presence of asthma, COPD and acute lung injury (Shahid et al. 2002; 
Gessner et al. 2003; Carpagnano et al. 2004; Ko et al. 2006). 
 
A previous study found correlations between the degree of 
bronchoalveolar neutrophilia, clinical signs of RAO and EBC H2O2 
concentration (Deaton et al. 2004a). In contrast, no significant difference 
was found in H2O2 concentration EBC between horses with or without LAI 
in the current study. For ethics and welfare reasons we did not perform a 
BAL and cytological analysis of BALF in control horses to confirm the 
absence of LAI. Further, horses with confirmed LAI in the current study 
had only mild clinical signs of respiratory disease. It is possible that horses 
with subclinical LAI were included in the healthy control group and 
therefore biased the results towards a non-significant difference between 
healthy and LAI groups. However, the results of the current study indicate 
that considerable variability exists in H2O2 concentration in EBC from 
individual horses both within and between days. This variability limits the 
usefulness of EBC H2O2 concentration as a diagnostic tool for the 
investigation of lower airway inflammation in individual horses, as it would 
not be possible to ascertain whether variability is the result of a 
physiological variation or sequela of an inflammatory process. With 
consideration of these findings, it is very likely that this variability 
minimized differences between healthy horses and those with LAI for H2O2 
concentration. However, horses with more marked LAI could have higher 
EBC H2O2 concentration as suggested by Deaton et al. (2004a) and 
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inclusion of such horses may have differentiated horses with LAI from 
healthy horses more clearly. 
 
6.2 Future Use of EBC H2O2 Analysis in the Horse 
 
From the results of the current studies, EBC H2O2 does not appear to be 
useful to monitor horses with LAI, particularly when disease is mild 
because it would be difficult to determine if a difference in EBC H2O2 
concentration is related to airway disease or physiological variations. 
Further investigations are required to determine whether concentrations 
of this putative marker of airway inflammation increase before the 
development of clinical signs of airway inflammation in horses, e.g. during 
exacerbations of RAO. If such a relationship exists, determination of H2O2 
concentration in EBC would be useful to achieve an earlier diagnosis of 
disease, allowing prompt initiation of therapy, reduced distress for the 
animal and expense for the owner. In addition, to determine whether a 
relationship between H2O2 concentration and severity of airway 
inflammation exists it would be useful studying the effect of an 
appropriate and effective environmental challenge in horses with RAO. 
While some studies have described variation in EBC H2O2 concentration 
after environmental challenge, the magnitude of the challenge was 
variable between studies and unlikely to be sufficient to induce 
considerable increase in EBC H2O2 concentration and conflicting results 
were reported between studies (Deaton et al. 2005a; Wyse et al. 2005). 
 
An inverse relationship has been described between EBC H2O2 
concentration and rate of airflow in the airways in humans, supporting the 
theory that a large amount is produced within the conducting airways 
(Schleiss et al. 2000). Monitoring air flow during collection of EBC from 
horses could be a possible solution for better standardization of data 
collection and analysis. In human studies this has been achieved by 
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placing a flow meter in the collection system and making patients breathe 
at a determined flow rate (Schleiss et al. 2000). Standardising the 
respiratory rate would not be possible in standing horses, however 
monitoring the expiratory flow rate could permit greater appreciation of 
effect of flow rate on EBC H2O2 concentration and a more objective 
assessment of this marker of inflammation in this species. Collection of 
EBC from horses in the current study was performed at tidal breathing in 
non-sedated horses that were permitted to become accustomed to the 
collection procedure. It is likely that monitoring the expiratory flow rates 
with flow-meters would allow a better understanding of the physiology of 
H2O2 release in EBC. Most portable flow-meters available commercially are 
too small (1cm internal diameter) for the use in horses and are expensive 
and investigation of the use of flow metres was beyond the scope of this 
thesis.  
 
6.3 Future for the Use of EBC pH Analysis in the Horse 
 
In the current study, EBC pH was found to have a good repeatability for 
both intra-day and inter-day measurements, comparable to the magnitude 
of variation described in human medicine (Vaughan et al. 2003; Borrill et 
al. 2005). Good repeatability is a fundamental requirement for the 
development of a test for diagnostic purposes and the daily monitoring of 
patients with LAI.  
 
The ideal method to measure EBC pH remains an unresolved topic of 
scientific debate in human medicine and many techniques have been 
described to improve pH stability of EBC samples. The principal limitation 
of the measurement of EBC pH in horses is the time necessary for the 
reading to stabilize (up to 20 minutes). However, good repeatability was 
observed when the same time period for measurement was provided. 
Preparation of EBC samples with argon deaeration or CO2 did not induce a 
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quicker reading but also made measurements less repeatable. Given that 
pH in equine EBC samples (mean 5.65; range 5.08-6.02) is considerably 
lower than the pH in human EBC samples (mean 7.7, range 7.4-8.8) 
(Vaughan et al. 2003) and measurement is more repeatable without 
deaeration or standardization with CO2, it is possible that differences in 
the composition of EBC are present between horses and humans. 
Environmental factors may also induce differences in EBC between horses 
and humans. Ammonia is known to be present in the stable environment 
at high concentrations (Seedorf et al. 2007) and it is possible that it may 
influence EBC pH. However, ammonia concentration in the horses’ 
environment was not measured in this study as equipment required for 
collection and measurement of this gas were not available. 
 
Future studies aimed to identify the constituents of equine EBC may 
contribute to an improved understanding of the physiology of EBC 
formation and the pathophysiology of lower airway inflammation. 
Furthermore, these studies could also provide information useful to 
optimize the measurement methods of EBC H2O2 concentration and pH.  
 
In the current study there was no statistically significant difference in EBC 
pH between healthy horses and those with LAI. However a trend for a 
decrease on EBC pH in horses with LAI was present (p=0.079) and this 
lack of significance could have been influenced by the small numbers in 
each group, differing environmental conditions between groups and 
absence of BALF cytology data from the control animals. Further studies 
with categorisation of both healthy horses and those with LAI by BAL 
cytology and the inclusion of horses with marked clinical signs in the LAI 
group could help determine whether measurement of pH of EBC is a 
useful screening test for LAI in horses. In addition, studies assessing the 
response to effective antigenic challenge in horses with RAO would help to 
assess the usefulness of EBC pH to monitor horses with this condition and 
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whether this analyte could provide an earlier diagnosis for prompt 
therapeutic intervention before the progression of clinical signs. 
 
Airway acidification has been shown to directly relate with disease status 
in human patients (Hunt et al. 2000; Tate et al. 2002; Gessner et al. 
2003; Niimi et al. 2004). Airway acidosis may have antimicrobial 
properties through the production of reactive nitrogen and oxygen species 
(Hunt et al. 2000). However, airway acidification reduces ciliary clearance 
as studies ex vivo have shown that a pH less than 6.5 substantially 
reduces or eliminates ciliary beating (Luk and Dulfano 1983) and increases 
mucus viscosity (Holma and Hegg 1989). These alterations to the health 
of the lower airways may induce reduced mucus clearance in vivo in 
asthmatic patients (Hunt et al. 2000). 
 
Future possible applications of quantification of markers of lower airway 
inflammation in exhaled breath and EBC include provision of evidence of 
treatment efficacy in treatment trials (management and/or 
pharmacological). Several human studies have investigated the effect of 
corticosteroids on disease status such as asthma and COPD, and found 
that treatment with these drugs induced a decrease in markers of 
inflammation in EBC (Antczak et al. 2000; Kharitonov et al. 2002; 
Kharitonov and Barnes 2004). It is also possible that in horses with 
infectious diseases, such as viral or bacterial pneumonia, collection of EBC 
could allow non-invasive monitoring of the efficacy of treatment and 
timely detection of deterioration in the condition of a patient.  
 
6.4 Conclusions 
 
The measurement of H2O2 concentration in EBC currently appears 
unsuitable for detection and monitoring of horses with mild LAI, due to 
large intra-day and inter-day variability and lack of a significant increase in 
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concentrations compared to healthy horses. It remains possible that 
quantification of EBC H2O2 concentration may be a useful indicator of 
severity of LAI, as reported previously (Deaton et al. 2004b), however 
further studies using larger numbers of horses with naturally occurring 
disease are required. 
 
While EBC pH had minimal variability within and between days, it did not 
appear to be a useful marker of mild LAI. Examination of horses with 
more severe LAI, for example acute RAO, may help to elucidate whether 
EBC pH is altered with airway inflammation. In human medicine a 
relationship between asthma pathophysiology and airway acidification has 
been documented (Hunt et al. 2000) and if a similar relationship between 
disease severity and airway pH exists in horses, such a finding could 
contribute to a better understanding of the pathogenesis of RAO.  
 
The studies described in this thesis have shown that the collection of EBC 
in horses is easy to perform and well tolerated. Therefore EBC analysis is 
a new avenue of equine respiratory medicine with great potential for 
future research and/or clinical application. Further studies should include 
investigation of the usefulness of other markers of inflammation e.g. 
cytokines, leukotrienes, proteins and nitric oxides for detection and 
quantification of LAI. Several of these parameters have been found to be 
useful for the detection of LAI in humans (Gessner et al. 2003; 
Carpagnano et al. 2004; Franklin et al. 2006; Ko et al. 2006). In addition 
determination of ammonia concentrations in EB would be useful to 
investigate the influence of this compound on EBC pH.  
 
In conclusion, the results of the current studies provide information on the 
variability of the concentrations of EBC H2O2 and pH in EBC obtained from 
both healthy horses and horses with LAI. Further a lack of difference in 
these parameters between healthy and disease horses was determined. 
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The results of these studies will serve to provide information upon which 
further studies of EBC analysis can be based. 
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APPENDIX 1 – List of manufacturers 
 
 
BMG LABTECH GmbH, Hanns-Martin-Schleyer-Str. 10, 77656 Offenurg, Germany 
 
BOC Gases, The Priestley Centre, 10 Priestley Road, Surrey Research Park, Guildford, 
Surrey, GU2 7XY, UK 
 
B&Q, Torrance House, Erskine, Renfrewshire, PA8 6AT, UK 
 
Cranlea and Company, The Sandpits, Acacia Road, Bournville, Birmingham, B30 2AH, UK 
 
Hanna Instruments Ltd., Eden Way, Pages Industrial Park, Leighton Buzzard, 
Bedfordshire, LU7 4AD, UK 
 
Microsoft Corporation, One Microsoft Way, Richmond, WA 98052- USA 
 
Minitab Inc, Minitab Headquarters , 3801 Enterprise Drive, State College, PA 16801, USA 
 
Sigma-Aldrich Company Ltd., The Old Brickyard, New Road, Gillingham, Dorset, SP8 4XT, 
UK 
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APPENDIX 2 – List of abbreviations 
 
am In the morning 
ANOVA Analysis of Variance 
ARDS Acute respiratory distress syndrome 
ATS/ERS American Thoracic Society/European Respiratory Society 
BAL Broncho-alveolar lavage 
BALF Broncho-alveolar lining fluid 
Bpm Breaths per minute 
°C Degree Celcius 
Cdyn Dynamic lung compliance 
cm Centrimetre 
COPD Chronic obstructive pulmonary disease 
CV Coefficient of variation 
EB Exhaled breath 
EBC Exhaled breath condensate 
EHV Equine Herpes Virus 
ERhV Equine Rhino Virus 
HRP Horse radish Peroxidase 
IAD Inflammatory airway disease 
IFN Interferon 
IL Interleukin 
IU/L International Unit per Litre 
L Litre 
LAI Lower airway inflammation 
LDL Lower detection limit 
LQL Lower quantification limit 
M Molar 
min Minute 
MIP-2 Macrophages inflammatory protein 2 
ml Millilitre 
NF New Fores 
nm Nanometre 
PaCO2 Partial pressure of carbon dioxyde in arterial blood 
PaO2 Partial pressure of oxygen in arterial blood 
pm In the afternoon 
PP Polypropylene 
RAO Recurrent airway obstruction 
RONS Reactive oxygen and nitrogen species 
RL Pulmonary resistance 
SD Standard deviation 
SPA-RAO Summer pasture associated – recurrent airway obstruction 
Spp. Species 
TA Tracheal aspirate 
TB Thoroughbred 
 135
TMB 3,3’,5,5’- tetramethylbenzydine 
TNF Tumor necrosis factor 
WB Warmblood 
X Cross 
y.o. Years old 
ΔPplmax Maximal change in pleural pressure 
μM Micromolar 
μL Microlitre 
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APPENDIX 3 – Figures of equipment for EBC collection 
 
Figure 1: the facemask used in the study was built from a plastic muzzle 
adapted with fibreglass and resin. Two openings were used to attach one-way 
valves 
 
 
Figure 2: inner view of the mask where two holes were left open and modelled 
with fibreglass and artificial resin to fit the attachment of the one-way valves 
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 Figure 3: A rubber ring was used to establish an air-tight connection between 
each one-way valve and the mask 
 
 
Figure 4: the rubber shroud sealed the mask on the muzzle of the horse 
creating a closed unidirectional circuit preventing contamination of the 
exhaled breath sample with ambient air and permitting generation of negative 
pressures necessary to activate the one-way valves. 
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Figure 5: One-way valves used in the study. Two valves were connected to the 
mask. Each valve has an internal diameter of 3.5cm and ensure a 
unidirectional flow of air during respiration by the horse 
 
 
Figure 6: A) The connection of the face mask to the condensation chamber 
was obtained through flexible rubber/plastic tubes; B) The device is used in 
the standing non-sedated horse 
B A 
 
 A B
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Figure 7: The condensation chamber has a one way valve (A) at the end of the 
system to isolate of from the environmental air. The PP chamber (B) in 
immersed in the ethanol/liquid nitrogen slurry 
 A B
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APPENDIX 4 – Figures of laboratory analysis of EBC 
Figure 1: A) The Horse Radish Peroxidase (HRP) was available as a powder 
and was reconstituted as a solution by adding 1.36ml of distilled water for 
every mg of powder; B) The TMB (3,3’,5,5’-tetramethylbenzidine) used was 
available in 1mg tablets and was prepared in solution mixing 1mg of TMB with 
0.5ml of Acetone, 0.5ml of methanol and 9ml of 0.42M citrate buffer solution 
(pH 3.84) 
 A B
 
 
Figure 2: A) Microplate ready for analysis with standard concentrations (0, 
0.1, 0.5, 1, 5 and 10μM) on the left and samples of EBC on the right. B)The 
spectrophotometer read the absorbance of each well (FLUOstar OPTIMA, BMG 
labtech, UK) at the  wavelength of 450nm 
B A 
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Figure 3: A) Electrochemical bench pHmeter and B) electrode (6mm diameter) 
used to measure the pH of exhaled breath condensate in sample as little as 
0.3ml  
A B
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